Quarterlytics / Industrials / Specialty Business Services / Network-1 Technologies

Network-1 Technologies

ntip · NYSE Industrials
Claim this profile
Ticker ntip
Exchange NYSE
Sector Industrials
Industry Specialty Business Services
Employees 1-10
← All annual reports
FY2022 Annual Report · Network-1 Technologies
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-K

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2022

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

For the transition period from ____________ to ___________.

Commission File Number: 1-15288

NETWORK-1 TECHNOLOGIES, INC.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
(State or Other Jurisdiction of
Incorporation or Organization)

11-3027591
(I.R.S. Employer
Identification Number)

65 Locust Avenue, Third Floor
          New Canaan, Connecticut 06840          
(Address of Principal Executive Offices)

Registrant's telephone number, including area code:   (203) 920-1055

Securities registered pursuant to Section 12(b) of the Act:

    Title of each class    
Common Stock $.01 par value

    Trading symbol    
NTIP

    Name of each exchange on which registered    
NYSE American

    Common Stock, $.01 par value    
(Title of Class)

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐    No ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934. Yes ☐    No ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes ☒    No ☐

 
 
 
 
 
 
 
 
 
                                           
 
                                           
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                           
 
 
 
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T

(§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes ☒    No ☐

Indicate  by  check  mark  whether  the  registrant  is  a  large  accelerated  filer,  an  accelerated  filer,  a  non-accelerated  filer,  a  smaller  reporting  company  or  an  emerging
growth  company.  See  the  definitions  of  “large  accelerated  filer,”  “accelerated  filer”,  “smaller  reporting  company”  and  “emerging  growth  company”  in  Rule  12b-2  of  the
Exchange Act.

Large accelerated filer  ☐

Non-accelerated filer  ☒

Emerging growth company  ☐

Accelerated filer  ☐

Smaller Reporting Company  ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised

financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Indicate  by  check  mark  whether  the  registrant  has  filed  a  report  on  and  attestation  to  its  management’s  assessment  of  the  effectiveness  of  its  internal  control  over

financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in this filing reflect

the correction of an error to previously issued financial statements. ☐ 

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of

the registrant’s executive officers during the relevant recovery period pursuant to §240.10D.1(b).  ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).   Yes ☐    No ☒

The aggregate market value of the voting and non-voting common stock held by non-affiliates computed by reference to the price at which the common stock was last
sold as of June 30, 2022 was approximately $39,885,677 based on the closing price as reported on NYSE American Exchange.  Shares of voting stock held by each officer and
director and by each person, who as of June 30, 2022, the last business day of the Registrant’s most recently completed second quarter, may be deemed to have beneficially
owned more than 10% of the voting stock have been excluded. This determination of affiliate status is not necessarily a conclusive determination of affiliate status for any other
purpose.

The number of shares outstanding of Registrant's common stock as of March 23, 2023 was 23,817,505.

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.
2022 FORM 10-K

TABLE OF CONTENTS

PART I

Item 1.       Business

Item 1A.   Risk Factors

Item 1B.    Unresolved Staff Comments

Item 2.       Properties

Item 3.       Legal Proceedings

Item 4.      Mine Safety Disclosures

PART II

Item 5.       Market For Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Item 6.       (Reserved)

Item 7.       Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 7A.   Quantitative and Qualitative Disclosures About Market Risk

Item 8.       Financial Statements and Supplementary Data

Item 9.       Changes in and Disagreements With Accountants on Accounting and Financial Disclosure

Item 9A.   Controls and Procedures

Item 9B.    Other Information

Item 9C.    Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

PART III

Item 10.     Directors, Executive Officers and Corporate Governance

Item 11.     Executive Compensation

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Item 13.    Certain Relationships and Related Transactions and Director Independence

Item 14.    Principal Accountant Fees and Services

PART IV

Item 15.     Exhibits and Financial Statement Schedules

Signatures

-1- 

Page No.

2

10

19

19

19

21

21

24

24

31

31

31

31

32

33

33

38

43

45

45

46

49

 
 
 
 
 
 
 
 
Forward-looking statements:

PART I

THIS  ANNUAL  REPORT  ON  FORM  10-K  CONTAINS  STATEMENTS  ABOUT  FUTURE  EVENTS  AND  EXPECTATIONS  WHICH  ARE  “FORWARD-LOOKING
STATEMENTS”.  ANY  STATEMENT  IN  THIS  10-K  THAT  IS  NOT  A  STATEMENT  OF  HISTORICAL  FACT  MAY  BE  DEEMED  TO  BE  A  FORWARD-LOOKING
STATEMENT  WITHIN  THE  MEANING  OF  SECTION  27A  OF  THE  SECURITIES  EXCHANGE  ACT  OF  1933,  AS  AMENDED,  OR  SECTION  21E  OF  THE
SECURITIES  EXCHANGE  ACT  OF  1934,  AS  AMENDED.  FORWARD-LOOKING  STATEMENTS  PROVIDE  CURRENT  EXPECTATIONS  OF  FUTURE  EVENTS
BASED  ON  CERTAIN ASSUMPTIONS AND  INCLUDE ANY  STATEMENT  THAT  DOES  NOT  DIRECTLY  RELATE  TO ANY  HISTORICAL  OR  CURRENT  FACT.
STATEMENTS CONTAINING SUCH WORDS AS “MAY,” “WILL,” “EXPECT,” “BELIEVE,” “ANTICIPATE,” “INTEND,” “COULD,” “ESTIMATE,” “CONTINUE” OR
“PLAN”  AND  SIMILAR  EXPRESSIONS  OR  VARIATIONS  ARE  INTENDED  TO  IDENTIFY  FORWARD-LOOKING  STATEMENTS.    THESE  STATEMENTS  ARE
BASED  ON  THE  BELIEFS AND ASSUMPTIONS  OF  OUR  MANAGEMENT  BASED  ON  INFORMATION  CURRENTLY AVAILABLE  TO  MANAGEMENT.  SUCH
FORWARD-LOOKING  STATEMENTS  ARE  SUBJECT  TO  CURRENT  RISKS,  UNCERTAINTIES  AND  ASSUMPTIONS  RELATED  TO  VARIOUS  FACTORS  SET
FORTH  IN  THIS  REPORT  AND  IN  OTHER  FILINGS  MADE  BY  US  WITH  THE  SECURITIES  AND  EXCHANGE  COMMISSION.  BASED  UPON  CHANGING
CONDITIONS, SHOULD ANY ONE OR MORE OF THESE RISKS OR UNCERTAINTIES MATERIALIZE, INCLUDING THOSE DISCUSSED AS “RISK FACTORS” IN
ITEM 1A AND ELSEWHERE IN THIS REPORT, OR SHOULD ANY OF OUR UNDERLYING ASSUMPTIONS PROVE INCORRECT, ACTUAL RESULTS MAY VARY
MATERIALLY  FROM  THOSE  DESCRIBED  IN  THIS  REPORT.  WE  UNDERTAKE  NO  OBLIGATION  TO  UPDATE,  AND  WE  DO  NOT  HAVE  A  POLICY  OF
UPDATING  OR  REVISING  THESE  FORWARD-LOOKING  STATEMENTS.  READERS  ARE  CAUTIONED  NOT  TO  PLACE  UNDUE  RELIANCE  ON  FORWARD-
LOOKING  STATEMENTS,  WHICH  SPEAK  ONLY AS  OF  THE  DATE  THE  STATEMENT  WAS  MADE.  UNLESS  THE  CONTEXT  OTHERWISE  REQUIRES,  THE
TERMS  “NETWORK-1,”  “COMPANY,”  “WE,”  “OUR,”  “US”  MEAN  NETWORK-1 TECHNOLOGIES,  INC. AND  ITS WHOLLY-OWNED  SUBSIDIARIES,  MIRROR
WORLDS TECHNOLOGIES, LLC AND HFT SOLUTIONS, LLC.

ITEM 1.   BUSINESS

Overview

Our principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-seven (97) U.S. patents, fifty-two (52)
of such patents have expired, and eight foreign patents relating to (i) our Cox patent portfolio (the “Cox Patent Portfolio”) relating to enabling technology for identifying media
content on the Internet and taking further actions to be performed after such identification; (ii) our M2M/IoT patent portfolio (the “M2M/IoT Patent Portfolio”) relating to,
among other

-2- 

 
 
 
 
 
 
things,  enabling  technology  for  authenticating,  provisioning  and  using  embedded  Sim  (Subscriber  Identification  Module)  technology  in  next  generation  IoT,  Machine-to-
Machine,  and  other  mobile  devices,  including  smartphones,  tablets  and  computers;  (iii)  our  HFT  patent  portfolio  (the  “HFT  Patent  Portfolio”)  covering  certain  advanced
technologies relating to high frequency trading, which inventions specifically address technological problems associated with speed and latency and provide critical latency
gains in trading systems where the difference between success and failure may be measured in nanoseconds; (iv) our Mirror Worlds patent portfolio (the “Mirror Worlds Patent
Portfolio”)  relating  to  foundational  technologies  that  enable  unified  search  and  indexing,  displaying  and  archiving  of  documents  in  a  computer  system;  and  (v)  our  remote
power patent (the “Remote Power Patent”) covering the delivery of Power over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless
access  ports,  IP  phones  and  network  based  cameras.    In  addition,  we  review  opportunities  to  acquire  or  license  additional  intellectual  property  as  well  as  other  strategic
alternatives.

We have invested $7,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company with an exclusive license to sixty-four (64) patents.
On December 31, 2022, we owned approximately 6.8% of the outstanding units of ILiAD on a non-fully diluted basis and 6.3% of the outstanding units on a fully diluted basis
(after giving effect to the exercise of all outstanding options and warrants).

Our current strategy includes continuing our efforts to monetize our intellectual property.  In addition, we continue to seek to acquire additional intellectual property
assets to develop, commercialize, license or otherwise monetize. Our strategy includes working with inventors and patent owners to assist in the development and monetization
of their patented technologies. Our patent acquisition and development strategy is to focus on acquiring high quality patents which management believes have the potential to
generate significant licensing opportunities as we have achieved with respect to our Remote Power Patent and our Mirror Worlds Patent Portfolio. In addition, we may also
enter into strategic relationships with third parties to develop, commercialize, license or otherwise monetize their intellectual property.

We have been dependent upon our Remote Power Patent for a significant portion of our revenue. We no longer receive licensing revenue for our Remote Power Patent

for any period subsequent to March 7, 2020 (the expiration date of the patent). Our future revenue is largely dependent on our ability to monetize our other patent assets.

We have pending litigation involving our assertion of infringement claims concerning certain patents within our Cox Patent Portfolio and our Remote Power Patent. In
addition, we have a pending appeal to the U.S. Court of Appeals for the Federal Circuit of the District Court judgment of non-infringement dismissing our case against Meta
Platforms, Inc. (formerly Facebook, Inc.) involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings” at pages 19-21 of this Annual Report).

At December 31, 2022, we had cash and cash equivalents and marketable securities of $48,439,000 and working capital of $47,359,000. Based on our current cash

position, we believe that we will have sufficient cash to fund our operations for the foreseeable future.

-3- 

 
 
 
 
We currently own ninety-seven (97) U.S. patents and eight foreign patents relating to patents within our Cox Patent Portfolio, M2M/IoT Patent Portfolio, HFT Patent
Portfolio,  Mirror  World  Patent  Portfolio  and  our  Remote  Power  Patent.  With  respect  to  our  ninety-seven  (97)  U.S.  patents,  fifty-two  (52)  of  such  patents  have  expired.
However, we can assert expired patents against third parties but only for past damages up to the expiration date. We currently have pending litigation involving expired patents
including our Remote Power Patent, and certain patents within our Cox and Mirror Worlds Patent Portfolios (see “Legal Proceedings” at pages 19-21 hereof).

Overview of Our Patents

Cox Patent Portfolio

Our  Cox  Patent  Portfolio,  acquired  from  Dr.  Ingemar  Cox  in  February  2013,  currently  consists  of  thirty-nine  (39)  U.S.  patents  relating  to  enabling  technology  for
identifying media content on the Internet, such as audio and video, and taking further actions to be performed based on such identification. All of the patents within our Cox
patent portfolio expired in September 2021 except for two patents which expire in July 2023 and November 2023. We have pending litigation against Google Inc. and YouTube,
LLC involving assertion of certain patents within our Cox Patent Portfolio (see “Legal Proceedings” at page 19 hereof). The patents within our Cox Patent Portfolio are based
on a patent application filed in 2000. Since the acquisition of the Cox Patent Portfolio in February 2013, we have been issued thirty-four (34) additional patents relating to this
portfolio. The claims in these thirty-four (34) additional patents are generally directed towards systems of content identification and performing actions following therefrom.

We  are  obligated  to  pay  Dr.  Cox  12.5%  of  the  net  proceeds  generated  by  us  from  licensing,  sale  or  enforcement  of  the  Cox  Patent  Portfolio.  Dr.  Cox  provides

consulting services to us with respect to the Cox Patent Portfolio and assists our efforts to develop the patent portfolio.

Dr. Cox is currently a Professor at the University of Copenhagen and University College London where he is head of its Information and Decision Systems Group. Dr.
Cox was formerly a member of the Technical Staff at AT&T Bell Labs and a Fellow at NEC Research Institute. He is a Fellow of the ACM, IEEE, the IET (formerly IEE), and
the British Computer Society and is a member of the UK Computing Research Committee. In 2019, Dr. Cox was the recipient of the Tony Kent Strix Award in recognition of
his contribution to the field of information retrieval. He was founding co-editor in chief of the IEE Proc. on Information Security and was an associate editor of the IEEE Trans.
on Information Forensics and Security. He is co-author of a book entitled “Digital Watermarking” and its second edition “Digital Watermarking and Steganography”. He is an
inventor or co-inventor of over seventy (70) U.S. patents.

-4- 

 
 
 
 
 
 
 
 
 
M2M/IoT Patent Portfolio

Our M2M/IoT Patent Portfolio, acquired in December 2017 from M2M and IoT Technologies, LLC (“M2M”), relates to, among other things, enabling technology for
authenticating, provisioning and using embedded SIM technology in next generation IoT, Machine-to-Machine and other mobile devices including smartphones, tablets and
computers as well as automobiles and drones. The M2M/IoT Patent Portfolio currently consists of thirty-four (34) issued U.S. patents, four pending U.S. patent applications,
seven registered foreign patents and seven additional pending non-U.S. patent applications. Since we acquired the M2M/IoT Patent Portfolio in December 2017, we have been
issued twenty-two (22) additional U.S. patents with respect to the portfolio. We anticipate further issuances of additional claims for this portfolio. The expiration dates of the
thirty-four (34) issued U.S. patents currently within our M2M/IoT Patent Portfolio range from September 2033 to May 2034.

We have an obligation to pay M2M 14% of the first $100 million of net proceeds (after deduction of expenses) and 5% of net proceeds greater than $100 million from
Monetization Activities (as defined) related to our M2M/IoT Patent Portfolio. In addition, M2M will be entitled to receive from us $250,000 of additional consideration upon
the occurrence of certain future events related to the patent portfolio.

John Nix, the Managing Member of M2M, provides consulting services to us with respect to our M2M/IoT Patent Portfolio. Mr. Nix is an entrepreneur and inventor,
and founder and Chief Executive Officer of Vobal Technologies, LLC. In 2016, Mr. Nix was recognized as “Creator of the Year” by the Intellectual Property Law Association
of Chicago for his intellectual property related to embedded SIM technology.

HFT Patent Portfolio

On March 25, 2022, we acquired the HFT Patent Portfolio. This portfolio covers certain advanced technologies relating to high frequency trading, which inventions
specifically address technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and
failure may be measured in nanoseconds. The HFT Patent Portfolio currently includes nine issued U.S. patents and two pending U.S. patents.

In addition to the purchase price that we paid at closing, we have an obligation to pay the seller an additional cash payment of $500,000 and $375,000 of our common
stock contingent upon achieving certain milestones with respect to the HFT Patent Portfolio. We also have an obligation to pay the seller 15% of the first $50 million of net
proceeds (after deduction of expenses) generated from the patent portfolio and 17.5% of net proceeds greater than $50 million.

Mirror Worlds Patent Portfolio

Our  Mirror  Worlds  Patent  Portfolio,  acquired  in  May  2013,  consists  of  ten  (10)  U.S.  patents  and  covers  foundational  technologies  that  enable  unified  search  and
indexing, displaying and archiving of documents in a computer system. All of our patents within our Mirror Worlds Patent Portfolio have expired. The Mirror Worlds Patent
Portfolio includes U.S. Patent No. 6,006,227 (the “227 Patent”), U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 which are currently being asserted in our litigation
against Meta Platforms, Inc. (formerly Facebook, Inc.) (see “Legal Proceedings” at pages 19-20 hereof). Our 227 Patent was previously asserted in litigations against Apple Inc.
and Microsoft Corporation which were settled resulting in aggregate payments to us of $29,650,000.

-5- 

 
 
The inventions relating to document stream operating systems covered by our Mirror Worlds Patent Portfolio resulted from the work done by Yale University computer
scientist, Professor David Gelernter, and his then graduate student, Dr. Eric Freeman, in the mid-1990s. Certain aspects of the technologies developed by David Gelernter were
commercialized in their company's product offering called “Scopeware.” Technologies embodied in Scopeware are now common in various computer and web-based operating
systems. Professor Gelernter and Dr. Freeman each entered into consulting agreements with us as part of our acquisition of the Mirror Worlds Patent Portfolio.

As part of our acquisition of the Mirror Worlds Patent Portfolio in 2013, we also entered into an agreement with Recognition Interface, LLC (“Recognition”), an entity
that financed the commercialization of the Mirror Worlds patent portfolio prior to its sale to Mirror Worlds, LLC and also retained an interest in the licensing proceeds of the
Mirror  Worlds  patent  portfolio.  Pursuant  to  the  terms  of  the  agreement  with  us,  we  are  obligated  to  pay  Recognition  an  interest  in  the  net  proceeds  realized  from  our
monetization of the Mirror Worlds Patent Portfolio as follows: (i) 10% of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20%
of  any  portion  of  the  net  proceeds  in  excess  of  $250  million.  Since  entering  into  the  agreement  with  Recognition  in  May  2013,  we  have  paid  Recognition  an  aggregate  of
$3,127,000 with respect to such net proceeds interest in our Mirror Worlds Patent Portfolio (no such payments were made during the years 2022 and 2021).

Remote Power Patent

Our Remote Power Patent (U.S. Patent No. 6,218,930) covers the delivery of power over Ethernet cables for the purpose of remotely powering network devices such
as wireless access ports, IP phones and network based cameras. Our Remote Power Patent expired on March 7, 2020. Notwithstanding the expiration of the Remote Power
Patent  in  March  2020,  we  are  currently  asserting  the  patent  in  separate  actions  against  five  defendants  for  damages  prior  to  March  7,  2020  (expiration  date)  (see  “Legal
Proceedings” at page 20 hereof).

On June 13, 2003, the Institute of Electrical Engineers (IEEE), a non-profit, technical professional association, approved the 802.3af Power over Ethernet standard (the
“Standard”), which covers technologies deployed in delivering power over Ethernet networks. The Standard provides for the Power Sourcing Equipment (PSE) to be deployed
in  switches  or  as  standalone  midspan  hubs  to  provide  power  to  remote  devices  such  as  wireless  access  points,  IP  phones  and  network-based  cameras.  The  technology  is
commonly referred to as Power over Ethernet (“PoE”). In 2009, the IEEE Standards Association approved 802.3at, a new PoE standard which, among other things, increased
the available power for delivery over Ethernet networks. We believe that our Remote Power Patent covers several of the key technologies covered by both the 802.3af and
802.3at standards.

-6- 

 
 
 
 
 
Network-1 Strategy

Our  strategy  is  to  capitalize  on  our  intellectual  property  assets  by  entering  into  licensing  arrangements  with  third  parties  that  utilize  our  intellectual  property's
proprietary technologies as well as any additional proprietary technologies covered by patents which may be acquired by us in the future. Our current patent acquisition and
development strategy is to focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as has been the
case with our Remote Power Patent and Mirror Worlds Patent Portfolio. Our Remote Power Patent has generated licensing revenue in excess of $187,000,000 from May 2007
through  December  31,  2022.  Since  acquisition  of  our  Mirror  Worlds  Patent  Portfolio  in  May  2013,  we  have  received  licensing  and  other  revenue  of  $47,150,000  through
December 31, 2022. In addition, we may enter into third party strategic relationships with inventors and patent owners to assist in the development and monetization of their
patent technologies. Based on our cash position, we review opportunities to acquire additional intellectual property as well as evaluate other strategic alternatives.

In connection with our activities relating to the protection of our intellectual property assets, or the intellectual property assets of third parties with whom we may have
strategic relationships in the future, it may be necessary to assert patent infringement claims against third parties whom we believe are infringing our patents or those of our
strategic partners. We are currently involved in several litigations to protect our patents including certain patents within our Cox Patent Portfolio, Mirror Worlds Patent Portfolio
and Remote Power Patent (see “Legal Proceedings” at pages 19-21 hereof). We have previously successfully asserted litigation with respect to our Remote Power Patent and
our Mirror Worlds Patent Portfolio and have also been successful in defending proceedings at the USPTO challenging the validity of our Remote Power Patent and certain
patents within our Cox Patent Portfolio.

-7- 

 
 
 
 
 
 
 
Significant Licensees

We had no revenue for the year ended December 31, 2022. Revenue from our Remote Power Patent constituted 100% of our revenue for the year ended December 31,

2021, of which two licensees constituted 99% of our revenue for such year.

Competition

With respect to our ability to acquire additional intellectual property assets or enter into strategic relationships with third parties to monetize their intellectual property
assets, we face considerable competition from other companies, many of which have significantly greater financial and other resources than we have. The patent licensing and
enforcement  industry  has  grown  and  there  has  been  a  material  increase  in  the  number  of  companies  seeking  to  acquire  intellectual  property  assets  from  third  parties  or  to
provide financing to third parties seeking to monetize their intellectual property. Entities including, among others, Acacia Research Corporation (NASDAQ:ACTG), Intellectual
Ventures,  WI-LAN  Inc.,  a  subsidiary  of  Quarterhill  Inc.  (NASDAQ:QTRH),  VirnetX  Holdings  Corporation  (NYSE  MKT:VHC)  and  RPX  Corporation,  seek  to  acquire
intellectual property or partner with third parties to license or enforce intellectual property rights. In addition, we also compete with strategic corporate buyers with respect to
the acquisition of intellectual property assets. It is expected that others will enter this market as well. Many of these competitors have significantly greater financial and human
resources than us.

We may also compete with litigation funding firms such as Burford Capital Limited, Validity Finance, LLC, Fortress Investment Group, LLC, Parabellum Capital LLC
and Bentham Capital LLC, venture capital firms and hedge funds for intellectual property acquisitions and licensing opportunities. Many of these competitors also have greater
financial resources and human resources than us.

Regulatory Environment

If new legislation, regulations or rules are implemented either by Congress, the USPTO or the courts that impact the patent application process, the patent enforcement
process or the rights of patent holders, these changes could negatively affect our business, financial condition and results of operations. Certain legislation, regulations, and
rulings by the courts and actions by the USPTO have materially increased the risk and cost of enforcement of patents. U.S. patent laws were amended by the Leahy-Smith
America Invents Act, referred to as the “America Invents Act”, which became effective on March 16, 2013. The America Invents Act included a number of significant changes
to  U.S.  patent  law.  In  general,  it  addressed  issues  surrounding  the  enforceability  of  patents  and  the  increase  in  patent  litigation  by,  among  other  things,  establishing  new
procedures for patent litigation and new administrative post-grant review procedures to challenge the patentability of issued patents outside of litigation, including Inter Partes
Review  (IPR)  and  Covered  Business  Method  Review  (CBM)  proceedings  which  provide  third  parties  a  timely  and  cost  effective  alternative  to  district  court  litigation  to
challenge  the  validity  of  an  issued  patent. The America  Invents Act  and  its  implementation  has  increased  the  uncertainties  and  costs surrounding  the  enforcement  of  patent
rights has made it more difficult to successfully enforce our patents.

-8- 

 
 
 
In addition, future changes in patent law could adversely impact our business. Such changes may not be advantageous to us and may make it more difficult to obtain
adequate  patent  protection  to  enforce  our  patents.  Increased  focus  on  the  growing  number  of  patent  lawsuits,  particularly  by  non-practicing  entities  (NPEs),  may  result  in
legislative changes which increase the risk and costs of asserting patent litigation.

Investment in ILiAD Biotechnologies

During the period December 2018 to date, we made an aggregate investment of $7,000,000 in ILiAD, a privately held clinical stage biotechnology company dedicated
to the prevention and treatment of human disease caused by Bordetella pertussis. ILiAD is currently focused on validating its proprietary intranasal vaccine, BPZE1, for the
prevention of pertussis (whooping cough). Pertussis is a life-threatening disease caused by the highly contagious respiratory bacterium Bordetella pertussis. According to the
U.S. Centers for Disease Control and Prevention, each year pertussis affects approximately 16 million people globally, accounting for nearly 200,000 deaths. ILiAD has the
exclusive license to sixty-four (64) issued patents and has thirty (30) pending patent applications. On December 31, 2022, we owned approximately 6.8% of the outstanding
units  of  ILiAD  on  a  non-fully  diluted  basis  and  6.3%  of  the  outstanding  units  on  a  fully  diluted  basis  (after  giving  effect  to  the  exercise  of  all  outstanding  options,  and
warrants). In connection with our investment, Corey Horowitz, our Chairman and Chief Executive Officer, became a member of ILiAD’s Board of Managers.

BPZE1 was developed in the laboratory of Camille Locht, PhD, at the Institut Pasteur de Lille (IPL) and French National Institute of Health and Medical research.
BPZE1 is a live-attenuated intranasal vaccine designed to overcome deficiencies of current pertussis vaccines, including poor durability of protection and failure to prevent
nasopharyngeal Bordetella pertussis infections that lead to escape mutants and transmission to vulnerable infants. On January 3, 2022, ILiAD announced that the U.S. Food and
Drug Administration (FDA) granted Fast Track designation for BPZE1.

On  August  24,  2022,  ILiAD  consummated  a  private  financing  of  $42,800,000  of  its  Class  D  units,  of  which  a  multi-national  pharmaceutical  company  invested
$30,000,000. As a result of the financing, we recognized a gain of $3,883,000 on our equity investment and a gain of $271,000 with respect to the conversion of our convertible
note in the principal amount of $1,000,000 plus interest into equity of ILiAD.

-9- 

 
 
  
Corporate Information

We were incorporated under the laws of the State of Delaware in July 1990. Our principal executive offices are located at 65 Locust Avenue, Third Floor, New Canaan,

Connecticut 06840 and our telephone number is (203) 920-1055.

Available Information

We  file  or  furnish  various  reports,  such  as  registration  statements,  quarterly  and  current  reports,  proxy  statements  and  other  materials  with  the  SEC.  Our  website
address is www.network-1.com. You may obtain, free of charge on our Internet website, copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current
reports on Form 8-K, proxy statements and amendments to those reports or statements filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act, as soon as
reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The information we post on our website is intended for reference purposes only;
none of the information posted on our website is part of this Annual Report or incorporated by reference herein.

In addition to the materials that are posted on our website, you may read and copy any materials we file with the SEC at the SEC's Public Reference Room at 100 F
Street,  NE,  Washington,  DC  20549.  You  may  obtain  information  on  the  operation  of  the  Public  Reference  Room  by  calling  the  SEC  at  1-800-SEC-0330.  The  SEC  also
maintains an Internet site that contains reports, proxy and other information statements, and other information regarding issuers, including us, that file electronically with the
SEC. The address of the SEC’s Internet site is http://www.sec.gov.

Employees and Consultants

We currently have two employees and two consultants providing monthly services to us.

ITEM 1A.    RISK FACTORS

Our operations and financial results are subject to various material risks and uncertainties, including those described below, which could adversely affect our business,
financial condition, results of operations, cash flow, and the trading price of our common stock. You should carefully consider the material risks and uncertainties described
below in addition to the other information set forth in this Annual Report on Form 10-K, including, but not limited to, the section titled “Management’s Discussion and Analysis
of  Financial  Condition  and  Results  of  Operations.”  The  material  risks  described  below  are  not  the  only  risks  we  face. Additional  risks  that  we  do  not  know  of  or  that  we
currently believe are immaterial may also impair our business operations. If any of the following risks actually occur, our business, financial condition, results of operations and
cash flow could be materially adversely affected, and the trading price of our common stock could decline significantly.

-10- 

 
 
 
 
Risks Related to Our Business

Our revenue from licensing intellectual property is uncertain as it is generally dependent upon litigation outcomes involving our patents which we cannot

predict.

Our revenue is dependent upon our litigation outcomes. We currently have pending litigation involving our Cox Patent Portfolio and Mirror Worlds Patent Portfolio as
well as our Remote Power Patent (see “Legal Proceedings” at pages 19-21 hereof). Patent litigation is inherently risky and uncertain and we cannot assure you that any of our
current or future litigation will result in a favorable outcome for us. Accordingly, our revenue is uncertain.

If we are unable to protect our patents, our business would be negatively impacted.

We  believe  our  patents  are  valid,  enforceable  and  valuable.  Despite  this  belief,  third  parties  typically  defend  assertion  of  our  patents  by  asserting  defenses,  among
others, of non-infringement and invalidity. In addition, in the future certain of our patents may be subject to USPTO post-grant inter partes review proceedings (IPRs) which
could result in all or a part of our patents being invalidated or the claims being limited. Unfavorable outcomes in our litigation or IPRs may reduce our ability to enforce our
patents or have other adverse consequences. If we are unable to protect our patents or otherwise realize value for them, our business would be negatively impacted.

The outcome of our substantial investment in ILiAD is uncertain.

To  date  we  have  invested  $7,000,000  in  ILiAD,  a  privately  held  clinical  stage  biotechnology  company,  with  focus  on  validating  its  proprietary  intranasal  vaccine
(BPZE1) for the prevention of pertussis (whopping cough). For the year ended December 31, 2022, we recorded a gain of $3,883,000 on our ILiAD investment in accordance
with Accounting Standards Codification (ASC) 323 as a result of ILiAD’s completion of a private financing of approximately $42,800,000 in August 2022 which included an
investment of $30,000,000 by a multi-national pharmaceutical company. We also recorded a gain in 2022 of $271,000 in connection with conversion of our convertible note in
the principal amount of $1,000,000 plus accrued interest into equity in the ILiAD private offering (see Note B[6] and Note H to our consolidated financial statements included
herein). Notwithstanding the gains we recorded in 2022, our investment in ILiAD remains subject to substantial risks.

We have been dependent upon our Remote Power Patent for a significant portion of our revenue and we may not be able to generate future revenue from

our other patents.

Our Remote Power Patent has generated licensing revenue for us in excess of $187,000,000 from May 2007 through December 31, 2022. We had no revenue in 2022
and revenue from our Remote Power Patent constituted 100% of our revenue for 2021 ($36,029,000), 2020 ($4,403,000) and 2019 ($3,037,000). As a result of the expiration of
our  Remote  Power  Patent  on  March  7,  2020,  we  no  longer  receive  licensing  revenue  from  such  patent  for  any  period  subsequent  to  the  expiration  date.  Our  failure  to
successfully monetize our other patents would have a negative impact on our business, financial condition and operating results.

-11- 

 
 
 
We may not achieve successful outcomes of our pending or future litigation which would have a negative impact on our business.

We are currently enforcing certain patents within our Cox Patent Portfolio against Google and YouTube, who are challenging these patents and we are also asserting
our  Remote  Power  Patent  in  nine  separate  litigations  against  ten  defendants. We  have  appealed  to  the  Federal  Circuit  the  District  Court  decision  granting  Facebook  (Meta
Platforms, Inc.), summary judgment of non-infringement and dismissing our case involving certain patents within our Mirror Worlds Patent Portfolio (see “Legal Proceedings”
at  pages  19-20  hereof).  In  addition,  our  M2M/IoT  Patent  Portfolio  and  HFT  Patent  Portfolio,  are  not  currently  being  asserted.  We  may  not  have  success  in  enforcing  or
defending our patents, which would have a negative impact on our business.

We may not be able to capitalize in the future on our strategy to acquire high quality patents with significant licensing opportunities or enter into strategic

relationships with third parties to license or otherwise monetize their intellectual property.

Based upon the success we achieved from licensing our Remote Power Patent (twenty-eight (28) license agreements which generated in excess of $187,000,000 of
revenue), the revenue we generated from our Mirror Worlds Patent Portfolio ($47,150,000) and establishing a patent portfolio currently consisting of ninety-seven (97) U.S.
patents and eight foreign patents as well as our cash position, we believe we have the expertise and sufficient capital to compete in the patent monetization market and to enter
strategic relationships with third parties to develop, commercialize, license or otherwise monetize their patents. Our strategy is to focus on acquiring high quality patent assets
which  management  believes  have  the  potential  for  significant  licensing  opportunities.  However,  we  may  not  be  able  to  acquire  such  additional  high  quality  patents  or,  if
acquired,  we  may  not  achieve  material  revenue  or  profit  from  such  patents.  Acquisitions  of  patent  assets  are  competitive,  time  consuming,  complex  and  costly  to
consummate. High quality patents with significant licensing opportunities are difficult to find and are often very competitive to acquire.  In addition, such acquisitions present
material risks. Even if we acquire such additional patent assets, we may not be able to achieve significant licensing revenue or even generate sufficient revenue related to such
patent assets to offset the acquisition costs and the legal fees and expenses which may be incurred to enforce, license or otherwise monetize such patents. In addition, we may
not  be  able  to  enter  into  strategic  relationships  with  third  parties  to  license  or  otherwise  monetize  their  intellectual  property  and,  even  if  we  consummate  such  strategic
relationships, we may not achieve material revenue or profit from such relationships.

-12- 

 
 
 
 
The patent monetization cycle is long, costly and unpredictable.

There is generally a significant time lag between acquiring a patent portfolio and recognizing revenue from those patent assets. During this time lag, significant costs
are likely to be incurred which may have a negative impact on our results of operations, cash flow and financial position. Furthermore, the outcome of our efforts to monetize
our patents is uncertain and we may not be successful.

Our quarterly and annual operating and financial results and our revenue are difficult to predict and are likely to fluctuate significantly in future periods.

Our quarterly and annual operating and financial results are difficult to predict and may fluctuate significantly from period to period. In 2022, we had no revenue and
incurred a net loss of $2,326,000. We had revenue of $36,029,000 and net income of $14,281,000 for 2021, as compared to revenue of $4,403,000 and a net loss of $1,709,000
for 2020. We had revenue of $3,037,000 and a net loss of $1,792,000 for 2019 as compared to revenue and net income of $22,106,000 and $7,706,000 for 2018. Accordingly,
our revenue, net income and results of operations may widely fluctuate as a result of a variety of factors that are outside our control including the timing and our ability to
achieve successful outcomes from current and future patent litigation, our ability and timing in consummating future license agreements for our intellectual property assets, the
timing and extent of payments received by us from licensees, whether we will achieve a successful outcome of our investment in ILiAD, and the timing and our ability to
achieve revenue from future strategic relationships.

In  the  future  we  could  be  classified  as  a  Personal  Holding  Company  resulting  in  a  20%  tax  on  our  PHC  Income  that  we  do  not  distribute  to  our

shareholders.

The  personal  holding  company  (“PHC”)  rules  under  the  Internal  Revenue  Code  impose  a  20%  tax  on  a  PHC’s  undistributed  personal  holding  company  income
(“UPHCI”), which means, in general, taxable income subject to certain adjustments and reduced by certain distributions to shareholders. For a corporation to be classified as a
PHC, it must satisfy two tests: (1) that more than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the
second half of the year (after applying constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other
related parties) (the “Ownership Test”) and (2) at least 60% of its adjusted ordinary gross income for a taxable year consists of dividends, interest, royalties, annuities and rents
(the “Income Test”). During the second half of 2022, based on available information concerning our shareholder ownership, we did not satisfy the Ownership Test and thus we
were not a PHC for 2022. However, we may be determined to be a PHC in the future.  If we were determined to be a PHC in 2023 or any future year, we would be subject to an
additional 20% tax on our UPHCI. In such event, we may issue a special cash dividend to our shareholders in an amount equal to the UPHCI rather than incur the 20% tax.

-13- 

 
 
 
 
We are dependent upon our CEO and Chairman.

Our success is largely dependent upon the personal efforts of Corey M. Horowitz, our Chairman, Chief Executive Officer and Chairman of our Board of Directors. On
March 22, 2022, we entered into a new four year employment agreement with Mr. Horowitz pursuant to which he continues to serve as our Chairman and Chief Executive
Officer. The loss of the services of Mr. Horowitz would have a material adverse effect on our business and prospects. We do not maintain key-man life insurance on the life of
Mr. Horowitz.

Cash dividends may not be continued to be paid.

Our  dividend  policy  consists  of  semi-annual  cash  dividends  of  $0.05  per  share  ($0.10  per  share  annually)  which  have  been  paid  in  March  and  September  of  each
year. We have paid such semi-annual dividends since our dividend policy was enacted in December 2016. At this time we anticipate continuing to pay dividends consistent with
our policy. However, our dividend policy undergoes a periodic review by our Board of Directors and is subject to change at any time depending upon our earnings, financial
requirements and other factors existing at the time.  We may not be in a position to continue to pay dividends in the future.

Legislation, regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcement of patents and may continue to

do so in the future.

Legislation, regulations, court rulings and actions by the USPTO have materially increased the risk and cost of enforcing patents. U.S. patent laws were amended by
the  Leahy-Smith America  Invents Act,  referred  to  as  the America  Invents Act,  which  became  effective  on  March  16,  2013. The America  Invents Act  included  a  number  of
significant  changes  to  U.S.  patent  law.  In  general,  it  addressed  issues  surrounding  the  enforceability  of  patents  and  the  increase  in  patent  litigation  by,  among  other  things,
established  new  procedures  for  patent  litigation  and  new  administrative  post-grant  review  procedures  to  challenge  the  patentability  of  issued  patents  outside  of  litigation,
including Inter Partes Review (IPR) and Covered Business Method Review (CBM) proceedings which provide third parties a timely, cost effective alternative to district court
litigation to challenge the validity of an issued patent. In addition, the America Invents Act changed the way that parties may be joined in patent infringement actions, and
increased the likelihood that such actions will need to be brought against individual parties allegedly infringing by their respective individual actions or activities. The America
Invents Act and its implementation also increased the uncertainties and costs surrounding the enforcement of patent rights, which could have a material adverse effect on our
business, financial condition and results of operations.

-14- 

 
 
 
 
Changes in patent law could adversely impact our business.

Patent laws may continue to change and may alter the protections afforded to owners of patent rights. Such changes may not be advantageous to us and may make it
more  difficult  to  obtain  adequate  patent  protection  to  enforce  our  patents.  Increased  focus  on  the  growing  number  of  patent  lawsuits,  particularly  by  non-practicing  entities
(NPEs), may result in further legislative changes which increase the risk and costs of asserting patent litigation.

Our pending patent infringement litigations are time consuming and costly.

We have pending litigations involving our Cox Patent Portfolio, Mirror Worlds Patent Portfolio (pending appeal to the Federal Circuit of dismissal of our Facebook
(Meta Platforms, Inc.) litigation) and Remote Power Patent (see “Legal Proceedings” at pages 19-21 of this Annual Report). While we have contingent legal fee arrangements,
or a contingency plus a fixed cash amount arrangement, with our patent litigation counsel in each litigation, we are responsible for all or a portion of the expenses which are
anticipated to be material. In addition, the time and effort required of our management to effectively pursue these litigations is likely to be significant and it may adversely
affect other business opportunities.

We face intense competition to acquire intellectual property and enter into strategic relationships.

With respect to our ability to acquire additional intellectual property or enter into strategic relationships with third parties to monetize their intellectual property, we
face considerable competition from other companies, many of which have significantly greater financial and other resources than we have. We face a number of competitors in
the patent licensing and enforcement business seeking to acquire intellectual property rights from third parties. Many of these competitors have significantly more financial and
human resources than us.

We  may  also  compete  with  strategic  corporate  buyers,  litigation  funding  firms,  venture  capital  firms  and  hedge  funds  for  intellectual  property  acquisitions  and

licensing opportunities. Many of these competitors have greater financial resources and human resources than us.

Our markets are subject to rapid technological change and our technologies face potential technology obsolescence.

The  markets  covered  by  our  intellectual  property  are  characterized  by  rapid  technological  changes,  changing  customer  requirements,  frequent  new  product
introductions and enhancements, and evolving industry standards. The introduction of products embodying new technologies and the emergence of new industry standards may
render our technologies obsolete or less marketable.

-15- 

 
 
 
 
 
In  addition,  other  companies  may  develop  competing  technologies  that  offer  better  or  less  expensive  alternatives  to  the  technologies  covered  by  our  intellectual
property. Moreover, technological advances or entirely different approaches developed by other companies or adopted by various standards groups could render our patents
obsolete, less marketable or unenforceable.

The burdens of being a public company may adversely affect us including our ability to pursue litigation.

As a public company, our management must devote substantial time, attention and financial resources to comply with U.S. securities laws. This may have a material
adverse effect on management's ability to effectively and efficiently pursue its business. In addition, our disclosure obligations under U.S. securities laws require us to disclose
information publicly that will be available to litigation opponents. We may, from time to time, be required to disclose information that may have a material adverse effect on our
litigation strategies. This information may enable our litigation opponents to develop effective litigation strategies that are contrary to our interests.

Investors may have limited influence on stockholder decisions because ownership of our common stock is concentrated.

General Risk Factors

As of March 10, 2023, our executive officers and directors beneficially owned 30.8% of our outstanding common stock. As a result, these stockholders may be able to
exercise  substantial  control  over  all  matters  requiring  stockholder  approval,  including  the  election  of  directors  and  approval  of  significant  corporate  transactions,  such  as  a
merger or other sale of our company or its assets. This concentration of ownership will limit other stockholders' ability to influence corporate matters and may have the effect of
delaying or preventing a third party from acquiring control over us.

Our common stock may be delisted from the NYSE American exchange if we fail to comply with continued listing standards.

Our common stock is currently traded on the NYSE American exchange under the symbol “NTIP”. If we fail to meet any of the continued listing standards of the

NYSE American exchange, our common stock could be delisted. Such delisting could adversely affect the price and trading (including liquidity) of our common stock.

-16- 

 
 
 
 
 
There are inherent uncertainties involved in estimates, judgments and assumptions used in the preparation of financial statements in accordance with U.S.

GAAP. Any changes in estimates, judgments and assumptions could have a material adverse effect on our business, financial condition, and operating results.

The preparation of financial statements in accordance with accounting principles generally accepted in the Unites States (“U.S. GAAP”) involves making estimates,
judgments  and  assumptions  that  affect  reported  amounts  of  assets  (including  intangible  assets),  liabilities  and  related  reserves,  revenues,  expenses,  and  income.  Estimates,
judgments, and assumptions are inherently subject to change in the future, and any such changes could result in corresponding changes to the amounts of assets, liabilities,
expenses, and income. Any such changes could have a material adverse effect on our business, financial condition, and operating results.

Provisions in our corporate charter, by-laws and in Delaware law could make it more difficult for a third party to acquire us, discourage a takeover and

adversely affect existing stockholders.

Our certificate of incorporation authorizes the Board of Directors to issue up to 10,000,000 shares of preferred stock. The preferred stock may be issued in one or more
series, the terms of which may be determined at the time of issuance by our Board of Directors, without further action by stockholders, and may include, among other things,
voting  rights  (including  the  right  to  vote  as  a  series  on  particular  matters),  preferences  as  to  dividends  and  liquidation,  conversion  and  redemption  rights,  and  sinking  fund
provisions, any of which could adversely affect holders of our common stock. Although there are currently no shares of preferred stock outstanding, future holders of preferred
stock may have rights superior to our common stock and such rights could also be used to restrict our ability to merge with or sell our assets to third parties.

We are also subject to the “anti takeover” provisions of Section 203 of the Delaware General Corporation Law, which could prevent us from engaging in a “business
combination” with a 15% or greater stockholder for a period of three years from the date such person acquired that status unless appropriate board or stockholder approvals are
obtained.

In addition, our By-laws contain advance notice requirements for director nominations and for new business to be brought up at stockholder meetings. Stockholders
wishing to submit director nominations or raise matters to a vote of stockholders must provide notice to us within specified date windows and in very specific forms in order to
have that matter voted on at a stockholders meeting.

The  aforementioned  provisions  could  deter  unsolicited  takeovers  or  delay  or  prevent  changes  in  our  control  or  management,  including  transactions  in  which
stockholders might otherwise receive a premium for their shares over the then current market price. These provisions may also limit the ability of stockholders to delay, deter or
prevent a change of control, or approve transactions that they may deem to be in their best interests.

-17- 

 
 
 
 
Our stock price may be volatile.

The  market  price  of  our  common  stock  may  be  highly  volatile  and  could  fluctuate  widely  in  price  in  response  to  various  factors,  many  of  which  are  beyond  our

control, including the following:

•

•

•

•

•

•

•

•

•

•

•

•

•

•

the outcome of our litigation against Google and YouTube involving certain patents within our Cox Patent Portfolio;

our ability to further develop, license and monetize our M2M/IoT Patent Portfolio;

our ability to further develop, license and monetize our HFT Patent Portfolio;

our ability to achieve a successful outcome of our investment in ILiAD;

the outcome of our appeal to the Federal Circuit of the District Court ruling granting Facebook summary judgment of non-infringement and dismissing
our case involving certain patents within our Mirror Worlds Patent Portfolio;

our ability to acquire additional intellectual property;

our ability to enter into strategic relationships with third parties to license or otherwise monetize their intellectual property;

variations in our quarterly and annual operating results;

our ability to continue to pay cash dividends;

our ability to raise capital if needed;

sales of our common stock;

technology changes;

legislative, regulatory and competitive developments; and

economic and other external factors.

In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of

particular companies. These market fluctuations may also have a material and adverse effect on the market price of our common stock.

-18- 

 
  
ITEM 1B.  UNRESOLVED STAFF COMMENTS

None.

ITEM 2.  PROPERTIES

Our principal executive offices are located in New Canaan, Connecticut, where we lease approximately 2,000 square feet of office space at a base rent of $5,500 per
month pursuant to a lease amendment, dated May 1, 2022, which term expires on April 30, 2025. We believe that our office facility is suitable and appropriate to support our
current needs.

ITEM 3.  LEGAL PROCEEDINGS

Cox Patent Portfolio Litigation

On April 4, 2014 and December 3, 2014, we initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court for the
Southern District of New York for infringement of several of our patents within our Cox Patent Portfolio which relate to the identification of media content on the Internet. The
lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of our patents by making, using, selling and offering to sell unlicensed systems and
related products and services, which include YouTube’s Content ID system.

The litigations against Google and YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings
then pending at the Patent Trial and Appeal Board (PTAB) and the appeals to the U.S. District Court of Appeals for the Federal Circuit. Pursuant to a joint stipulation and order,
entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two litigations against Google
and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not yet been set.

Mirror Worlds Patent Portfolio Litigation

Meta (Facebook) Litigation

On May 9, 2017, Mirror Worlds Technologies, LLC, our wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc., “Meta”) in
the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No. 8,255,439 (among
the patents within our Mirror Worlds Patent Portfolio). The lawsuit alleges that the asserted patents are infringed by Meta’s core technologies that enable Meta’s Newsfeed and
Timeline features. We seek, among other things, monetary damages based upon reasonable royalties.

On May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018, the Court issued an order granting Facebook’s motion for
summary judgment of non-infringement and dismissed the case. On January 23, 2020, the U.S. Court of Appeals for the Federal Circuit ruled in our favor and reversed the
summary judgment finding on non-infringement of the District Court and remanded the litigation to the Southern District of New York for further proceedings.

-19- 

 
 
 
On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In its ruling the Court (i) denied
Meta’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary judgment
of non-infringement in favor of Facebook and dismissed the case. We strongly disagree with the decision on non-infringement and on April 4, 2022 we filed an appeal to the
U.S. Court of Appeals for the Federal Circuit. The appeal is pending.

Remote Power Patent Litigation

October-November 2022 Litigation

In October and November 2022, we initiated nine separate litigations against ten defendants for infringement of our Remote Power Patent seeking monetary damages

based upon reasonable royalties, as follows:

•

•

•

•

On October 6, 2022, we initiated such litigation against Arista Networks, Inc., Fortinet, Inc., Honeywell International Inc. and Ubiquiti Inc. in the United
States District Court, District of Delaware;

On October 27, 2022, and November 3, 2022, we initiated such litigation against TP-Link USA Corporation and Hikvision USA, Inc. in the United States
District Court for the Central District of California;

On November 4, 2022, we initiated such litigation against Panasonic Holdings Corporation and Panasonic Corporation of North America in the United
States District Court for the Eastern District of Texas (Marshall Division); and

On November 8, 2022 and November 16, 2022, we initiated such litigation against Antaira Technologies, LLC and Dahua Technology USA in the United
States District Court for the Central District of California.

During the period January 24, 2023 through March 10, 2023, we entered into settlement agreements with Arista Networks, Inc., Antaira Technologies, LLC, Panasonic
Holdings  Corporation  and  TP-Link  USA  Corporation  with  respect  to  the  above  referenced  litigations  resulting  in  aggregate  settlement  payments  to  us  of  $537,300  and  a
conditional payment of $150,000.

-20- 

 
 
 
Netgear Litigation

On  December  15,  2020,  we  filed  a  lawsuit  against  Netgear  in  the  Supreme  Court  of  the  State  of  New York,  County  of  New York,  for  breach  of  a  Settlement  and
License Agreement, dated May 22, 2009, with us for Netgear’s failure to make royalty payments, and provide corresponding royalty reports to us based on sales of Netgear’s
PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration with the American Arbitration Association (“AAA”) seeking to arbitrate certain issues raised in the
litigation in the Supreme Court, State of New York, County of New York. We have objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the
New York court action alleging that we breached the License Agreement by not offering Netgear lower royalties. On September 22, 2022, the arbitration brought by Netgear
was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York.

ITEM 4.  MINE SAFETY DISCLOSURES

None.

PART II

ITEM 5.MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES

Market Information. Our common stock is listed for trading on the NYSE American exchange under the symbol “NTIP”. On March 23, 2023, the closing price for our
common  stock  as  reported  on  the  NYSE American  Exchange  was  $2.10  per  share.  The  number  of  record  holders  of  our  common  stock  was  39  as  of  March  23,  2023.  In
addition, we believe there were in excess of approximately 1200 holders of our common stock in “street name” as of March 23, 2023.

Dividend  Policy.    Our  dividend  policy  consists  of  semi-annual  cash  dividends  of  $0.05  per  share  ($0.10  per  share  annually)  which  have  been  paid  in  March  and
September of each year.  On February 23, 2022, our Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 24, 2022 to all
common shareholders of record as of March 9, 2022. On September 9, 2022, our Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment
date of September 30, 2022 to all common shareholders of record as of September 20, 2022. On March 3, 2023, our Board of Directors declared a semi-annual cash dividend of
$0.05 per share with a payment date of March 31, 2023 to all common shareholders of record as of March 15, 2023. At this time we anticipate continuing to pay dividends
consistent  with  our  policy.  However,  our  dividend  policy  undergoes  a  periodic  review  by  our  Board  of  Directors  and  is  subject  to  change  at  any  time  depending  upon  our
earnings, financial requirements and other factors existing at the time.

-21- 

 
 
 
 
 
 
 
As of December 31, 2022, we accrued dividends of $37,000 for unvested restricted stock units with dividend equivalent rights.

Recent Issuances of Unregistered Securities. There were no unregistered sales of equity securities during the quarter ended December 31, 2022.

Stock Repurchases. On June 11, 2021, our Board of Directors authorized an extension and increase of the share repurchase program (“Share Repurchase Program”) to
repurchase up to $5,000,000 of shares of our common stock over the subsequent 24 month period. The common stock may be repurchased from time to time in open market
transactions or privately negotiated transactions in our discretion. The timing and amount of the shares repurchased is determined by management based on its evaluation of
market conditions and other factors. The Share Repurchase Program may be increased, suspended or discontinued at any time.

-22- 

 
 
 
 
 
 
 
 
 
 
 
 
 
During the months of October, November and December 2022, we repurchased common stock pursuant to our Share Repurchase Program as indicated below:

Period

October 1, 2022 to
October 31, 2022

November 1, 2022 to
November 30, 2022

December 1, 2022 to
December 31, 2022

Total

Total Number of
Shares Purchased

Average Price
Paid Per Share

—

4,210

46,027

50,237

—

$2.23

$2.20

$2.20

Maximum Number
(or Approximate
Dollar Value) of
Shares) that May
Yet Be Purchased
Under the Plans or
Programs

$3,508,374

3,498,965

3,397,891

Total Number of
Shares Purchased
as Part of Publicly
Announced Plans
or Programs

—

4,210

46,027

50,237

During the year ended December 31, 2022, we repurchased an aggregate of 228,530 shares of our common stock pursuant to our Share Repurchase Program at a cost

of $531,000 (exclusive of commissions) or an average price per share of $2.33.

Since inception of our Share Repurchase Program (August 2011) to December 31, 2022, we repurchased an aggregate of 9,212,664 shares of our common stock at a

cost of $17,758,000 (exclusive of commissions) or an average per share price of $1.93.

Equity Compensation Plan Information

The following table summarizes share and exercise price information for our equity compensation plans as of December 31, 2022.

Number of
securities to be
issued upon
exercise of
outstanding
options and rights
(a)

625,000(1)

$ —

625,000    

Weighted-average
exercise price of
outstanding
options and
rights
(b)

Number of securities remaining
available for future issuance under
equity compensation plans
(excluding securities reflected in
column(a))
(c)

$ —(2)

$ —

$ —

2,300,000(3)

—

2,300,000

Equity compensation plans

approved by security holders

Equity compensation plans not
approved by security holders

Total

(1)       Consists of shares issuable upon vesting of outstanding restricted stock units issued under the 2013 Stock Incentive Plan.

(2)       Does not take into account outstanding restricted stock units as these awards have no exercise price.

(3)       Represents shares of common stock reserved for issuance under our 2022 Stock Incentive Plan. We have discontinued issuing awards under our 2013 Stock Incentive
Plan as a result of adoption of the 2022 Stock Incentive Plan.

-23- 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
           
Our  2022  Stock  Incentive  Plan  (“2022  Plan”)  provides  for  the  grant  of  any  or  all  of  the  following  types  of  awards:  (a)  stock  options,  (b)  restricted  stock  units  (c)
restricted  stock,  (d)  stock  appreciation  rights,  (e)  unrestricted  stock  awards,  (f)  cash  based  awards,  and  (g)  other  stock-based  awards. Awards  under  the  2022  Plan  may  be
granted singly, in combination, or in tandem.  Subject to standard anti-dilution adjustments as provided in the 2022 Plan, the 2022 Plan provides for an aggregate of 2,300,000
shares  of  our  common  stock  to  be  available  for  distribution  pursuant  to  the  2022  Plan.   The  Compensation  Committee  (or  the  Board  of  Directors)  will  generally  have  the
authority to administer the 2022 Plan, determine participants who will be granted awards under the 2022 Plan, the size and types of awards, the terms and conditions of awards
and  the  form  and  content  of  the  award  agreements  representing  awards. Awards  under  the  2022  Plan  may  be  granted  to  our  employees,  directors  and  consultants. As  of
December 31, 2022, there were no awards outstanding under our 2022 Plan and 625,000 shares issuable upon vesting restricted stock units under our 2013 Stock Incentive Plan
(“2013 Plan”).

ITEM 6. (RESERVED)

Not applicable.

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the financial statements and related notes
contained elsewhere in this Annual Report on Form 10-K. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual
results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below
and elsewhere in this Annual Report on Form 10-K, particularly in the “Risk Factors” Section on pages 10-18 hereof.

OVERVIEW

Our principal business is the development, licensing and protection of our intellectual property assets. We presently own ninety-seven (97) U.S. patents and [eight]
foreign patents relating to: (i) our Cox Patent Portfolio relating to enabling technology for identifying media content on the Internet and taking further action to be performed
after  such  identification;  (ii)  our  M2M/IoT  Patent  Portfolio  relating  to,  among  other  things,  enabling  technology  for  authenticating,  provisioning  and  using  embedded  Sim
(Subscriber Identification Module) technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) our
HFT Patent Portfolio covering certain advanced technologies relating to high frequency trading, which inventions specifically address technological problems associated with
speed  and  latency  and  provide  critical  latency  gains  in  trading  systems  where  the  difference  between  success  and  failure  may  be  measured  in  nanoseconds;  (iv)  our  Mirror
Worlds Patent Portfolio relating to foundational technologies that enable unified search and indexing, displaying and archiving of documents in a computer system; and (v) our
Remote  Power  Patent  covering  the  delivery  of  power  over  Ethernet  (PoE)  cables  for  the  purpose  of  remotely  powering  network  devices,  such  as  wireless  access  ports,  IP
phones and network based cameras. In addition, we continually review opportunities to acquire or license additional intellectual property as well as other strategic alternatives.

-24- 

 
 
 
At  December  31,  2022,  our  principal  sources  of  liquidity  consisted  of  cash  and  cash  equivalents  and  marketable  securities  of  $48,439,000  and  working  capital  of

$47,359,000. Based on our cash position, we continually review opportunities to acquire additional intellectual property as well as evaluate other strategic opportunities.

To date we have invested $7,000,000 in ILiAD, a clinical stage biotechnology company with an exclusive license to sixty-four patents. Although in 2022 we recorded

gains on our investment in ILiAD as referenced below, our investment continues to involve significant risk and the outcome is uncertain.

We  had  no  revenue  for  the  year  ended  December  31,  2022.  During  the  year  ended  December  31,  2022,  we  recorded  a  gain  on  our  equity  investment  in  ILiAD  of
$3,883,000 in accordance with ASC 323 due to an observable transaction price and dilution to our ownership of ILiAD as a result of an ILiAD private offering as well as a gain
on conversion of our convertible note from ILiAD of $271,000 in the private offering (see Note B[6] and Note H to our consolidated financial statements included herein).

We have been dependent upon our Remote Power Patent for a significant portion of our revenue. Our Remote Power Patent generated licensing revenue in excess of
$187,000,000 from May 2007 through December 31, 2022. We no longer receive licensing revenue for our Remote Power Patent for any period subsequent March 7, 2020 (the
expiration  date  of  the  patent).  During  the  fourth  quarter  of  2022,  we  commenced  separate  litigation  against  ten  defendants  involving  our  Remote  Power  Patent  for  patent
infringement for the period prior to March 7, 2020 (see “Legal Proceedings” on page 20 hereof).

In addition, we have pending litigation involving certain patents within our Cox Patent Portfolio and have appealed the judgment of the District Court dismissing our
litigation against Meta (Facebook) on the grounds of non-infringement involving certain patents within our Mirror Worlds Portfolio. We also intend to commence efforts to
monetize  certain  patents  within  our  M2M/IoT  Patent  Portfolio  and  HFT  Patent  Portfolio. We  may  not  achieve  successful  outcomes  of  such  litigation,  the  appeal,  or  future
litigation involving our patent assets.

Our current strategy includes continuing our licensing efforts with respect to our intellectual property assets and the monetization of our patent portfolios. In addition,
we continue to seek to acquire additional intellectual property assets to develop, commercialize, license or otherwise monetize. Our strategy includes working with inventors
and patent owners to assist in the development and monetization of their patented technologies. We may also enter into strategic relationships with third parties to develop,
commercialize, license or otherwise monetize their intellectual property. Our patent acquisition and development strategy is to focus on acquiring high quality patents which
management believes have the potential to generate significant licensing opportunities as we have achieved with respect to our Remote Power Patent and Mirror Worlds Patent
Portfolio.

-25- 

 
 
 
 
On March 25, 2022, we completed the acquisition of a new patent portfolio (the HFT Patent Portfolio) currently consisting of nine U.S. patents and two pending U.S.

patents (see Note I[2] to our consolidated financial statements included in this Annual Report).

The significant components of expenses impacting our net income include income tax expense as a result of transactions with our equity method investment in ILiAD.
Other significant components of expenses impacting our net income when revenue is recorded relate to contingent legal fees and expenses related to our patent litigation (see
Note  I[1]  to  our  consolidated  financial  statements  included  herein)  and  incentive  compensation  payable  to  our  Chairman  and  Chief  Executive  Officer  pursuant  to  his
employment agreement (see Note J to our consolidated financial statements included herein), both such components of expenses are based on a percentage of the licensing
revenue received by us as a result of litigation or otherwise.

Our annual and quarterly operating and financial results may fluctuate significantly from period to period as a result of a variety of factors that are outside our control,
including  the  timing  and  our  ability  to  achieve  successful  outcomes  of  our  patent  litigation,  our  ability  and  timing  of  consummating  future  license  agreements  for  our
intellectual property, and whether we will achieve a return on our investment in ILiAD and the timing of any such return.

Our future operating results may also be materially impacted by our ability to acquire high quality patents which management believes have the potential to generate
significant  licensing  opportunities.  In  the  future,  we  may  not  be  able  to  identify  or  consummate  such  patent  acquisitions  or,  if  consummated,  achieve  significant  licensing
revenue with respect to such acquisitions.

In  2023  and  future  years  we  could  be  classified  as  a  Personal  Holding  Company.  If  this  is  the  case,  we  would  be  subject  to  a  20%  tax  on  the  amount  of  any
undistributed personal holding company income (as defined) for such year that we do not distribute to our shareholders (see Note E to our consolidated financial statements
included in this Annual Report).

On June 9, 2021, our Board of Directors approved the continuation of our dividend policy consisting of semi-annual cash dividends of $0.05 per share ($0.10 per share
annually) which have been paid in March and September of each year. In 2022 and 2021, we paid semi-annual cash dividends in accordance with our dividend policy. At this
time we anticipate continuing to pay dividends consistent with our policy. However, our dividend policy undergoes a periodic review by our Board of Directors and is subject to
change at any time depending upon our financial requirements, earnings and other factors existing at the time (see Note O to our consolidated financial statements included
herein).

-26- 

 
 
 
 
RESULTS OF OPERATIONS

Year Ended December 31, 2022 Compared to Year Ended December 31, 2021

Revenue. We had no revenue for the year ended December 31, 2022 (“2022”) as compared to revenue of $36,029,000 for the year ended December 31, 2021 (“2021”).
Revenue for 2021 resulted from our resolution of a contractual dispute with Cisco concerning licensing of our Remote Power Patent and our litigation settlement with Hewlett-
Packard.

Operating Expenses. Operating expenses for 2022 were $3,903,000 as compared to $16,443,000 for 2021.

We had costs of revenue of $-0- and $12,147,000 for 2022 and 2021, respectively. Included in the costs of revenue for 2021 were contingent legal fees of $10,346,000
and  incentive  bonus  compensation  of  $1,801,000  payable  to  our  Chairman  and  Chief  Executive  Officer  pursuant  to  his  employment  agreement  (see  Note  J[1]  to  our
consolidated financial statements included herein).

Professional fees and related costs were $809,000 for 2022 as compared to $1,500,000 for 2021 as a result of decreased expenses related to patent litigation.

Stock-based compensation was $585,000 for 2022 as compared to $238,000 for 2021. The increase in stock-based compensation expense was due to the issuance of
restricted  stock  units  to  our  Chairman  and  Chief  Executive  Officer  pursuant  to  his  employment  agreement  (see  Note  J[1]  to  our  consolidated  financial  statements  included
herein).

Operating (Loss) Income. We had an operating loss of $3,903,000 for 2022 compared with operating income of $19,586,000 for 2021. The operating loss for 2022 was

due to no revenue for the period as compared to revenue of $36,029,000 for 2021.

Interest and Dividend Income. Interest and dividend income for 2022 was $1,020,000 as compared to $327,000 for 2021 primarily as a result of a change in the mix of

our short term fixed income investments and cash equivalents to higher yielding investments as interest rates were rising in 2022.

Gain on Conversion of Note. For 2022, we recorded a gain on conversion of our ILiAD convertible note of $271,000 as compared to $-0- for 2021 as a result of the

conversion of the ILiAD convertible note and accrued interest into equity of ILiAD (see Note H to our consolidated financial statements included herein).

Gain on Equity Method Investment. For 2022, we recorded a gain on our equity method investment in ILiAD of $3,883,000 as compared to $-0- for 2021, as a result of
an unrealized gain in connection with ILiAD’s August 2022 private offering, which was accounted for as an observable price transaction (see Note B[6] and Note H to our
consolidated financial statements included herein).

-27- 

 
 
 
 
Realized and Unrealized Loss on Marketable Securities. For 2022, we recorded realized and unrealized losses on marketable securities of $1,351,000 as compared to

$173,000 for 2021. The increased loss of $1,178,000 was due to unfavorable market conditions in the fixed income mutual funds market in 2022 compared to 2021.

Income Taxes. For 2022, we had $-0- current income tax for federal, state and local income taxes and a deferred tax expense of $607,000. For 2021, we had a current
tax  expense  for  federal,  state  and  local  income  taxes  of  $2,952,000  and  a  deferred  tax  expense  of  $1,508,000. The  net  decrease  of  income  tax  expense  of  $3,853,000  was
primarily due to no revenue in 2022.

Share of Net Losses of Equity Method Investee. We incurred net losses of $1,639,000 and $999,000 during 2022 and 2021, respectively, related to our equity method
investment in ILiAD. The increase of $640,000 in the net losses of ILiAD includes an additional loss of $398,000 as a result of new information received from ILiAD in the
fourth quarter of 2022 (see Note B[6] and Note H to our consolidated financial statements included herein).

Net  (Loss)  Income. As  a  result  of  the  foregoing,  we  incurred  a  net  loss  of  $2,326,000  or  $0.10  per  share  basic  and  diluted  for  2022  compared  with  net  income  of
$14,281,000  or  $0.59  per  share  basic  and  $0.58  per  share  diluted  for  2021.    Our  net  loss  for  2022  was  due  to  having  no  revenue  and  our  continuing  operating  expenses
supporting our patent portfolios, offset by our gain on equity method investment of $3,883,000 and interest and dividend income of $1,020,000. In comparison, we had revenue
of $36,029,000 for 2021 from the resolution of our contractual dispute with Cisco and our litigation settlement with Hewlett-Packard.

LIQUIDITY AND CAPITAL RESOURCES

We have financed our operations primarily from revenue from licensing our patents. At December 31, 2022, our principal sources of liquidity consisted of cash and
cash equivalents and marketable securities of $48,439,000 and working capital of $47,359,000. Based on our current cash position, we believe that we will have sufficient cash
to fund our operations for the next twelve months and the foreseeable future. Material increases in our liquidity and capital resources are primarily dependent upon litigation
outcomes and licensing of our intellectual property as well as whether we will be able to achieve returns on our investment in ILiAD.

Working capital decreased by $8,306,000 at December 31, 2022 to $47,359,000 as compared to working capital of $55,665,000 at December 31, 2021.  The decrease
in  working  capital  was  primarily  due  to  our  operating  loss  of  $3,903,000,  payment  of  income  taxes  of  $3,004,000,  cash  dividends  paid  of  $2,455,000,  and  an  additional
investment of $1,000,000 in ILiAD.

-28- 

 
 
 
 
Net cash (used in) provided by operating activities for 2022 decreased by $24,935,000 from $19,499,000 provided by operating activities for 2021 to $5,436,000 used
in operating activities for 2022, primarily due to no revenue in 2022 as compared to revenue of $36,029,000 for 2021. In addition, in 2022 we paid $3,004,000 in income taxes
related to 2021 taxable income.

Net  cash  (used  in)  provided  by  investing  activities  during  2022  was  $(22,271,000)  as  compared  to  $2,994,000  for  2021,  primarily  as  a  result  of  the  differential  of

increased purchases and decreased sales of marketable securities.

Net cash used in financing activities for 2022 and 2021 was $3,342,000 and $3,501,000, respectively. The reduction of $159,000 primarily resulted from repurchases
of our common stock of $534,000 for 2022 compared to $1,077,000 of repurchases for 2021 and offset by an increase of $341,000 in the value of shares delivered to fund
withholding taxes for 2022.

We maintain our cash in money market funds, government securities, certificates of deposit, and short-term fixed income securities. Accordingly, we do not believe

that our investments have significant exposure to interest rate risk.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements.

CONTRACTUAL OBLIGATIONS

We do not have any long-term debt, capital lease obligations, purchase obligations or other long-term liabilities except for our lease obligations for our principal office

space (see Note I[4] to our consolidated financial statement included herein).

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

Our discussion and analysis of our financial condition, results of operations and cash flows are based on our audited consolidated financial statements which have been
prepared in accordance with GAAP. The preparation of our financial statements included in this Annual Report on Form 10-K requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported
amounts of revenues and expenses during the reporting periods. The significant estimates and assumptions made in the preparation of our consolidated financial statements
include revenue recognition, contingent legal fees and related expenses, income taxes, valuation of patents and equity method investments. Actual results could be materially
different from those estimates, upon which the carrying values were based. See also Note B to our consolidated financial statements included in this Annual Report for full
disclosure of our accounting policies.

-29- 

 
 
 
 
We believe our most critical accounting policies and estimates to be the following:

Equity Method Investments

Equity  method  investments  are  equity  securities  in  entities  that  we  do  not  control  but  over  which  we  have  the  ability  to  exercise  significant  influence.  These
investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note B[6] hereof).
Equity method investments are measured at cost minus impairment, if any, plus or minus our share of an investee’s income or loss, and adjustments based on the investees
observable price transactions, if any. Our proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When our carrying value
in an equity method investment is reduced to zero, no further losses are recorded in our financial statements unless we guaranteed obligations of the investee company or have
committed additional funding. When the investee company subsequently reports income, we will not record our share of such income until it equals the amount of our share of
losses not previously recognized. In the event the equity method investee enters into an observable price transaction, the Company will increase or decrease the carrying value
in its equity method investment based on the transaction price. Upon sale of equity method investments, the difference between sales proceeds and the carrying amount of the
equity investment is recognized in profit or loss. In determining whether an equity method investment is impaired, we take into consideration a variety of factors including the
operating and financial performance of the investee, the investee’s future business plans and projections, discussions with the investee’s management, and our intent and ability
to hold the investment until it recovers in value. Accordingly, we make assumptions and estimates in assessing whether an impairment has occurred and if, in the future, our
assumptions and estimates made in assessing the fair value of these investments change, this could result in a material decrease in the carrying value of the investment. This
would cause us to write-down the carrying value of the investment and could have a material adverse effect on our results of operations in the period the impairment charge is
taken.

Income Taxes

We account for income taxes in accordance with Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 740, Income Taxes
(ASC 740), which requires us to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized
for the tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying
amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income taxes
of  a  change  in  tax  rates  is  recognized  in  income  in  the  period  that  includes  the  enactment  date. A  valuation  allowance  is  recognized  if  it  is  more  likely  than  not  that  some
portion, or all, of a deferred tax asset will not be realized. In evaluating the need for a valuation allowance, we estimate future taxable income based on management business
plans. This  process  involves  significant  management  judgment  about  assumptions  that  are  subject  to  change  from  period  to  period.  Because  the  recognition  of  deferred  tax
assets  requires  management  to  make  significant  judgments  about  future  earnings,  the  periods  in  which  items  will  impact  taxable  income  and  the  application  of  inherently
complex tax laws, we have identified the assessment of deferred tax assets and the need for any related valuation allowance as a critical accounting estimate.

-30- 

 
 
 
 
ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not applicable.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

The consolidated financial statements required hereby are located on pages F-1 through F-23 which follow Part III.

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE

None.

ITEM 9A. CONTROLS AND PROCEDURES

(a)    Evaluation of Disclosure Controls and Procedures

Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of
the Securities Exchange Act of 1934) as of the end of the period covered by this Annual Report on Form 10-K. Based upon this review, our executive officers concluded that, as
of the end of the period covered by this Annual Report on Form 10-K, our disclosure controls and procedures are effective to ensure that information required to be disclosed by
us in the reports we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported, within the time periods specified in applicable
rules and forms and is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding
required disclosure.

(b)   Internal Control Over Financial Reporting

(i)       Management’s Annual Report on Internal Control over Financial Reporting

Our management is also responsible for establishing and maintaining adequate “internal control over financial reporting” of the Company, as defined in Rule 13a-15(f)
of the Exchange Act.  Internal control over financial reporting is defined as a process designed by, or under the supervision of, the issuer’s principal executive and principal
financial officer and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the

-31- 

 
 
preparation of financial statements for external purposes in accordance with generally accepted accounting principles.  A company’s internal control over financial reporting
includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of
the  assets  of  the  company;  (ii)  provide  reasonable  assurance  that  transactions  are  recorded  as  necessary  to  permit  preparation  of  financial  statements  in  accordance  with
generally  accepted  accounting  principles,  and  that  receipts  and  expenditures  of  the  company  are  being  made  only  in  accordance  with  authorizations  of  management  and
directors  of  the  company;  and  (iii)  provide  reasonable  assurance  regarding  prevention  or  timely  detection  of  unauthorized  acquisition,  use,  or  disposition  of  the  company’s
assets that could have a material effect on the financial statements.

Because  of  its  inherent  limitations,  internal  control  over  financial  reporting  may  not  prevent  or  detect  misstatements.  Also,  projections  of  any  evaluation  of
effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies
or procedures may deteriorate.

Management, our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our internal control over financial reporting as
of  December  31,  2022  using  the  criteria  set  forth  by  the  Committee  of  Sponsoring  Organizations  of  the  Treadway  Commission  (COSO)  in  Internal  Control  -  Integrated
Framework (2013).  Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our internal controls over financial reporting were
effective as of the end of the period covered by this report.

(ii)     Attestation Report of Registered Public Accounting Firm

We are a “smaller reporting company” as defined in Rule 12b-2 promulgated under the Securities Exchange Act of 1934, as amended, and as such, are not required to
provide the information contained in this sub-section pursuant to Item 308(b) of Regulation S-K. Accordingly, this Annual Report on Form 10-K does not include an attestation
report of our registered public accounting firm regarding internal control over financial reporting.

(iii)     Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended December 31, 2022, that has materially affected, or is

reasonably likely to materially affect, our internal control over financial reporting.

ITEM 9B. OTHER INFORMATION

None.

-32- 

 
 
ITEM 9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS

Not Applicable.

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE

PART III

The following information includes information each director and executive officer has given us about his or her age, all positions he or she holds, his or her principal
occupation and business experience for at least the past five years, and the names of other publicly-held companies of which he or she currently serves as a director or has
served as a director during the past five years. In addition to the information presented regarding each director’s specific experience, qualifications, attributes and skills that led
our Board to the conclusion that he or she should serve as a director, we also believe that all of our directors have a reputation for integrity, honesty and adherence to high
ethical standards. They each have demonstrated business acumen, exercise sound judgment, and a commitment of service to Network-1 and our Board.

Information  about  the  number  of  shares  of  our  common  stock  beneficially  owned  by  each  executive  officer  and  director  appears  in  this Annual  Report  under  the
heading “Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters” beginning on page 43 hereof. There are no family relationships
among any of our directors and executive officers.

NAME

Corey M. Horowitz

Jonathan E. Greene

Robert M. Mahan

Emanuel R. Pearlman

Niv Harizman

Allison Hoffman

AGE

POSITION

Chairman, Chief Executive Officer and Chairman of the Board of Directors

Executive Vice President, Secretary and a Director

Chief Financial Officer

Director

Director

Director

68

61

56

63

58

52

-33- 

 
 
 
 
 
 
 
 
 
Corey M. Horowitz has been our Chairman and Chief Executive Officer since December 2003. Mr. Horowitz has also served as Chairman of our Board of Directors
since January 1996 and has been a member of our Board of Directors since April 1994. In December 2018, Mr. Horowitz became a member of the Board of Managers of ILiAD
Biotechnologies, LLC, a privately held biotechnology company, in connection with our investment in the company (see “Business-Investment in ILiAD Biotechnologies” at
page 9 of this Annual Report). Mr. Horowitz is also a member of the Life Sciences Institute Leadership Council at the University of Michigan. We believe Mr. Horowitz’s
qualifications to serve on our Board of Directors include his significant experience and expertise as an executive in the intellectual property field, his understanding of our
intellectual property and the patent acquisition, licensing and enforcement business combined with his private equity and corporate transactional experience.

Jonathan E. Greene became our Executive Vice President in October 2013 and our Secretary and a member of our Board of Directors in September 2022. He served as
a consultant to the Company from December 2004 until March 2013, providing technical and marketing analysis for our intellectual property portfolio. Mr. Greene became an
employee  of  Network-1  in  March  2013.  From April  2006  to  February  2009,  Mr.  Greene  served  as  a  marketing  consultant  for Avatier  Corporation,  a  developer  of  identity
management  software.  From August  2003  until  December  2004,  he  served  as  a  consultant  to  Neartek,  Inc.,  a  storage  management  software  company  (August  2003  until
October 2003) and Kavado Inc., a security software company (November 2003 until December 2004). We believe Mr. Greene’s qualifications to serve on our Board include his
engineering and technical expertise to assist us in our patent acquisition, licensing and enforcement business.

Robert  M.  Mahan  became  our  Chief  Financial  Officer  in  December  2022.  Mr.  Mahan  currently  serves  as  President  of  Management  and  Financial  Services,  Inc.,  a
consulting firm that he founded in 2011 which provides general management, financial and operations consulting services to private and public companies. From May 2021 to
February 2022, Mr. Mahan served as Interim Chief Financial Officer of Loft Orbital Solutions, Inc., a space infrastructure company that designs, launches and operates low
earth orbit satellites. From April 2019 to May 2021, he served as the Interim Chief Financial Officer of XWELL, Inc., formerly XpresSpa Group, Inc., (NASDAQ: XWEL), a
global health and wellness holding company operating XpresCheck®, XpresSpa®, and Treat™ locations in airports. From November 2016 through April 2019, Mr. Mahan
served as the Chief Financial Officer of SkyBell Technologies, Inc., a company engaged in the video doorbell and smart home industry. Mr. Mahan began his career in the audit
practice of PricewaterhouseCoopers from 1989 through 1992 and as a Controller/Division Chief Financial Officer of Tommy Hilfiger USA, Inc. from 1992 – 2001.

Emanuel R. Pearlman has been a member of our Board of Directors since January 2012, where he serves as Chairman of our Audit Committee and a member of our
Nominating and Corporate Governance Committee. Mr. Pearlman currently serves as the Chairman and Chief Executive Officer of Liberation Investment Group, a New York
based investment management and financial consulting firm, which he founded in January 2003. In March 2023, Mr. Pearlman became a member of the Board of Directors of
QualTek

-34- 

 
 
 
Services Inc. (NASDAQ:QTEK, a leading turnkey provider of infrastructure services to North American 5G wireless, telecom, power grid modernization and renewable energy
sectors. Mr. Pearlman also serves as a member of the Special Committee of the Board to review and approve strategic and financial alternatives. In March 2023, Mr. Pearlman
also  became  a  member  of  the  Board  of  Directors  of  MidCap  Financial  Investment  Corporation  (NASDAQ:MFIC),  a  closed-end  externally  managed,  non-diversified
management  investment  company  that  has  elected  to  be  treated  as  a  business  development  company.  Mr.  Pearlman  also  serves  on  the  Audit,  Nominating  and  Corporate
Governance, and Compensation Committee of MidCap Financial Investment Corp. In February 2023, Mr. Pearlman became a member of the Board of Directors of Diebold
Nixdorf, Inc. (NYSE: DBD), a multinational financial and retail technology company, and serves as a member of its Finance Committee and the People and Compensation
Committee.  From  March  2022  to April  2022,  he  was  a  member  of  the  Board  of  Directors  and  Chair  of  the  Strategic  Review  Committee  of  Red  Box  Entertainment,  Inc.
(NASDAQ:RDBX), an entertainment company that provides consumers access to a large variety of content across digital and physical media. From October 2020 to September
2021, Mr. Pearlman was a member of the Board of Directors of Atlas Crest Investment Corp. (NYSE:ACIC) and during the period February 2021 until June 2022, he served on
the Board of Directors of Atlas Crest Investment Corp. II (NYSE:ACII), each entity is a special purpose acquisition company (SPAC). Mr. Pearlman served as Chairman of the
Audit Committee and a member of the Compensation Committee and Nomination & Governance Committee of Atlas Crest Investment Corp. until September 2021 and held
the same committee positions for Atlas Crest Investment Corp. II until June 2022. Mr. Pearlman served as Executive Chairman of Empire Resorts, Inc. (NASDAQ:NYNY)
from June 2016 until November 2019, served as Non-Executive Chairman of the Board from September 2010 through May 2016, and served on the Board of Directors from
May 2010 to November 2019. Mr. Pearlman was a member of the Board of Directors of CEVA Logistics, AG (SIX:CEVA) from May 2018 until October 2019 and served on its
Audit  Committee  from  May  2018  through  October  2019  and  its  Nomination  and  Governance  Committee  from  May  2018  through  May  2019.  We  believe  Mr.  Pearlman’s
qualifications to serve on our Board include his significant investment and financial experience and expertise combined with his Board experience.

Niv Harizman has been a member of our Board of Directors since December 2012. Mr. Harizman is a Managing Member of Tyto Capital Partners LLC, a private
investment firm specializing in debt and equity investments in middle market companies and special situations, a position he has held since August 2010. Since March 2010,
Mr. Harizman has also been the Managing Member of NHK Partners LLC, an entity that makes private investments and provides consulting services. Since November 2013,
Mr.  Harizman  has  been  affiliated  with  Riverside  Management  Group,  a  merchant  banking  firm,  and  BCW  Securities  LLC,  its  affiliated  broker-dealer.    We  believe  Mr.
Harizman’s qualifications to serve on our Board include his significant investment and financial transactional experience and expertise.

Allison Hoffman has been a member of our Board of Directors since December 2012. Since August 2020, Ms. Hoffman has served as General Counsel of Phreesia, Inc.
(NYSE:PHR),  a  leading  provider  of  software  solutions  that  healthcare  organizations  use  to  manage  the  patient  intake  process.  From  January  2016  until August  2020,  Ms.
Hoffman served as Chief Legal Officer and Chief Administrative Officer at Intersection Parent, Inc., an urban experience company that utilizes technology to make cities better,
including  bringing  free Wi-Fi  throughout  New York  City.   We  believe  that  Ms.  Hoffman’s  qualifications  to  serve  on  our  Board  include  her  extensive  legal  background  and
transactional experience.

-35- 

 
 
 
 
Committees of the Board of Directors

Our  Board  of  Directors  currently  has  four  standing  committees:  an  Audit  Committee;  a  Compensation  Committee;  a  Nominating  and  Corporate  Governance
Committee and a Strategic Development Committee. Each of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee has a
charter.    These  charters  are  available  on  our  website  at:  http://ir.Network-1.com/governance-docs.  Each  member  of  each  committee  is  an  “independent”  director  under  the
standards  of  the  NYSE  American  LLC  Company  Guide.  Three  of  our  current  five  directors,  Emanuel  Pearlman,  Allison  Hoffman  and  Niv  Harizman,  are  considered
independent directors under Rule 803A(2) of the NYSE American LLC Company Guide.

Audit Committee

Our Board of Directors has a separately standing audit committee in accordance with Section 3(a)(58)(A) of the Securities Exchange Act of 1934, as amended, and
Section  803B  of  the  NYSE  American  Company  LLC  Guide  consisting  of  Emanuel  Pearlman  (Chairman)  and  Allison  Hoffman.  Emanuel  Pearlman  qualifies  as  an  audit
committee  financial  expert  under  applicable  SEC  rules.  Mr.  Pearlman  and  Ms.  Hoffman  qualify  as  “independent”  as  independence  for  audit  committee  members  is  defined
under Rule 10A-3 under the Securities Exchange Act of 1934, as amended, and Section 803B(2) of the NYSE American LLC Company Guide.

The Audit Committee is appointed by our Board of Directors to provide assistance to the Board in fulfilling its oversight responsibility with respect to, among other
things, (i) the integrity of our financial statements, (ii) our compliance with legal and regulatory requirements, (iii) selecting and evaluating the qualifications and independence
of our independent registered public accounting firm, (iv) evaluating the performance of our internal audit function and independent registered public accounting firm, and (v)
our internal controls and procedures.

Compensation Committee

The Compensation Committee consists of Allison Hoffman (Chair) and Niv Harizman. The Compensation Committee is appointed by our Board of Directors to assist
the  Board  in  carrying  out  its  responsibilities  relating  to  compensation  of  our  executive  officers  and  directors.   The  Committee  has  overall  responsibility  for  evaluating  and
approving the officer and director compensation plans, policies and our programs.

-36- 

 
 
 
Nominating and Corporate Governance Committee

Our Board has a Nominating and Corporate Governance Committee consisting of Niv Harizman (Chairman) and Emanuel Pearlman.  The Nominating and Corporate
Governance Committee is responsible for, among other things, developing and recommending to the Board a set of corporate governance policies for the Company, establishing
criteria  for  selecting  new  directors,  and  identifying,  screening  and  recruiting  new  directors.  The  Committee  also  recommends  to  the  Board  nominees  for  directors  and
recommends directors for committee membership to the Board.

Strategic Development Committee

We also have a Strategic Development Committee to assist our Chairman and Chief Executive Officer in strategic development and planning of our business relating
to identifying potential strategic partners, the acquisition of new IP and other acquisition opportunities.  The Committee also assists in capital markets related activities. Niv
Harizman is the sole member of the Strategic Development Committee.

Code of Ethics

We have adopted a Code of Ethics that applies to our executive officers, directors and employees. Copies of the Code of Ethics may be obtained, without charge, upon

written request addressed to: Network-1 Technologies, Inc., 65 Locust Avenue, Third Floor, New Canaan, Connecticut 06840, Attn: Chief Executive Officer.

-37- 

 
 
 
 
 
 
 
 
ITEM 11.     EXECUTIVE COMPENSATION

The following table summarizes compensation for the years ended December 31, 2022 and December 31, 2021, awarded to, earned by or paid to our Chief Executive
Officer (“CEO”) and to each of our executive officers who received total compensation in excess of $100,000 for the year ended December 31, 2022 for services rendered in all
capacities to us (collectively, the “Named Executive Officers”).

Summary Compensation Table

Name and
Principal Position

Corey M. Horowitz

Chairman and Chief Executive Officer

David C. Kahn

Chief Financial Officer

Jonathan Greene

Year

2022
2021

2022
2021

Salary ($)

Bonus ($)

$
$

$
$

535,000   
535,000   

175,000   
175,000   

$
$

$
$

    175,000(2) 
1,976,000(2) 

— 
22,500 

Stock
Awards($)(3)

$
$

$
$

1,102,940 
— 

— 
— 

All Other
Compensation($)
(1)

  Total($)

$
$

$
$

109,675(4) 
38,500(4) 

17,282(5) 
29,291(5) 

$
$

$
$

1,922,615 
2,549,500 

192,282 
226,791 

Executive Vice President
______________________________________________
(1) We have concluded that the aggregate amount of perquisites and other personal benefits paid in 2022 and 2021 to either Mr. Horowitz, Mr. Kahn or Mr. Greene did not

2022
2021

$
$

200,000   
200,000   

$
$

25,000 
40,000 

$
$

41,100(3) 
— 

$
$

20,419(6) 
36,120(6) 

$
$

286,519
276,120 

exceed $10,000.

(2) Mr. Horowitz received for 2022 an annual discretionary bonus of $175,000. Mr. Horowitz received the following cash incentive bonus payments for 2021: (i) an annual
discretionary  bonus  of  $175,000  and  (ii)  incentive  bonus  compensation  of  $1,801,000  pursuant  to  his  employment  agreement  (see  “Employment  Agreements  –
Termination of Employment Agreement and Change in Control Arrangements” below).

(3) The  amounts  in  this  column  represent  the  aggregate  grant  date  fair  value  of  restricted  stock  units  awards  granted  to  the  Named  Executive  Officers  computed  in
accordance with FASB ASC Topic 718. In accordance with SEC rules, the grant date fair value of an award that is subject to a performance condition is based on the
probable  outcome  of  the  performance  condition.  See  Note  B[10]  to  our  consolidated  financial  statements  included  in  this  Annual  Report  for  a  discussion  of  the
assumptions made by the Company in determining the grant date fair value.

(4) Includes 401(k) matching funds contributions by the Company and profit sharing under the Company's 401(k) Plan for the benefit of Mr. Horowitz of $40,500 for 2022
and $38,500 for 2021, respectively. Also includes dividends (dividend equivalent rights) on restricted stock units owned by Mr. Horowitz for 2022 of $69,175 and 2021
of $-0-.

(5) Includes  profit  sharing  under  the  Company's  401(k)  Plan  for  the  benefit  of  Mr.  Kahn  of  $17,282  for  2022  and  $28,728  for  2021. Also  includes  dividends  (dividend
equivalent  rights)  on  restricted  stock  units  owned  by  Mr.  Kahn  for  2022  and  2021  of  $-0-  and  $563,  respectively.  Mr.  Kahn  retired  as  Chief  Financial  Officer  of  the
Company on December 21, 2022.

(6) Represents profit sharing under the Company's 401(k) Plan for the benefit of Mr. Greene of $20,419 for 2022 and $35,201 for 2021. Also includes dividends (dividend

equivalent rights) on restricted stock units owned by Mr. Greene for 2022 and 2021 of $-0- and $919, respectively.

-38- 

 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
   
 
    
 
  
 
 
  
 
 
  
 
 
  
 
   
 
 
   
 
 
 
 
   
 
    
 
  
 
 
  
 
 
  
 
 
  
 
   
 
 
 
   
 
 
 
 
 
   
 
    
 
  
 
 
  
 
 
  
 
 
  
 
   
 
 
   
 
 
 
 
 
Narrative Disclosure to Summary Compensation Table

Employment Agreements, Termination of Employment and Change-In-Control Arrangements

On March 22, 2022, we entered into a new employment agreement (“Agreement”) with Corey M. Horowitz, our Chairman and Chief Executive Officer, pursuant to
which he continues to serve as our Chairman and Chief Executive Officer for a four year term (“Term”), at an annual base salary of $535,000 which shall be increased by 3%
per annum during the Term. The Agreement established an annual target bonus of $175,000 for our Chairman and Chief Executive Officer based upon performance. For the
year ended December 31, 2022 and 2021, our Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000.

In addition, pursuant to the Agreement, we granted to our Chairman and Chief Executive Officer, under our 2013 Plan, 600,000 restricted stock units (the “RSUs”,
each RSU awarded by us to our officers, directors and consultants represents a contingent right to receive one share of our common stock) which terms provided for vesting in
four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024, subject to Mr. Horowitz’s continued
employment by us through each such vesting date (the “Employment Condition”) (“Tranche 1”); (2) 150,000 RSUs shall vest if at any time during the Term our common stock
achieves  a  closing  price  for  twenty  (20)  consecutive  trading  days  (“Closing  Price”)  of  a  minimum  of  $3.50  per  share  (subject  to  adjustment  for  stock  splits)  and  the
Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the
Term our common stock achieves a Closing Price of a minimum of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through
the  date  such  minimum  per  share  Closing  Price  is  achieved  (“Tranche  3”);  and  (4)  125,000  RSUs  shall  vest  if  at  any  time  during  the Term,  our  common  stock  achieves  a
Closing Price of a minimum of $4.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share
Closing Price is achieved (“Tranche 4”).  In the event of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by Mr. Horowitz for
Good Reason (as defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions)
and all RSUs shall become immediately fully vested. All RSUs granted by us to our officers, directors or consultants have dividend equivalent rights.

Under  the  terms  of  the  Agreement,  so  long  as  Mr.  Horowitz  continues  to  serve  as  an  executive  officer  of  the  Company,  whether  pursuant  to  the  Agreement  or
otherwise, Mr. Horowitz shall also receive incentive compensation in an amount equal to 5% of our gross royalties or other payments from Licensing Activities (as defined)
(without deduction of legal fees or any other expenses) with respect to our Remote Power Patent and a 10% net interest (gross royalties and other payments after deduction of
all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no event shall he receive less than 6.25% of the gross recovery) of our royalties
and  other  payments  relating  to  Licensing  Activities  with  respect  to  patents  other  than  our  Remote  Power  Patent  (including  all  of  our  existing  patent  portfolios  and  our
investment  in  ILiAD)  (collectively,  the  “Incentive  Compensation”).  During  the  year  ended  December  31,  2022  and  December  31,  2021,  Mr.  Horowitz  earned  Incentive
Compensation of $-0- and $1,801,000, respectively.

-39- 

 
 
 
 
The Incentive Compensation shall continue to be paid to Mr. Horowitz for the life of each of our patents with respect to licenses entered into with third parties during
the Term or at any time thereafter, whether he is employed by us or not; provided, that, the employment of Mr. Horowitz has not been terminated by us “For Cause” (as defined)
or terminated by him without “Good Reason” (as defined). In the event of a merger or sale of substantially all of our assets, we have the option to extinguish the right of Mr.
Horowitz to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such future interest as determined
by an independent third party expert if the parties do not reach agreement as to such value. In the event that Mr. Horowitz’s employment is terminated by us “Other Than For
Cause” (as defined) or by him for “Good Reason” (as defined), Mr. Horowitz shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-
rated portion of the $175,000 target bonus provided bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii)
accelerated vesting of all unvested options, RSUs or other awards.

In connection with the Agreement, Mr. Horowitz has also agreed not to compete with us as follows: (i) during the Term and for a period of 12 months thereafter if his
employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 month base salary severance amount and (ii) for a period of two years from the
termination date, if terminated “For Cause” by us or “Without Good Reason” by Mr. Horowitz.

Jonathan Greene serves as our Executive Vice President and Secretary on an at-will basis at an annual base salary of $200,000. Mr. Greene received a discretionary
annual bonus of $25,000 for 2022 and $40,000 in 2021. On December 29, 2020, Mr. Greene was granted 10,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the
one year anniversary of the date of grant (December 29, 2021) and 50% of such RSUs vested on the two year anniversary of the grant (December 29, 2022). On January 18,
2022, Mr. Greene was granted 15,000 RSUs under the 2022 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (January 18, 2023) and 50% of
such RSUs vest on the two year anniversary of the grant (January 18, 2024), subject to Mr. Greene’s continued employment.

David Kahn served as our Chief Financial Officer on an at-will basis at an annual base salary of $175,000, until his retirement in December 2022. On December 29,
2020, Mr. Kahn was granted 7,500 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the grant (December 29, 2021) and 50% of such RSUs
vested on the two year anniversary of the grant (December 29, 2022). In connection with his retirement, Mr. Kahn was granted severance of six months base salary and certain
other benefits.

-40- 

 
 
 
Robert Mahan serves as our Chief Financial Officer as of December 21, 2022 on a consulting basis at an annual compensation of $175,000.

Profit Sharing 401(k) Plan

We offer all employees who have completed a year of service (as defined) participation in a 401(k) retirement savings plan, which provides a tax-advantaged method
of saving for retirement. We expensed matching contributions and profit sharing of $78,000 and $102,000 under the 401(k) plan for the years ended December 31, 2022 and
2021, respectively.

Director Compensation

In 2022, we compensated each non-management director of our Company by granting to each such outside director 15,000 RSUs. The RSUs vested in equal amounts
of 3,750 RSUs on each of March 15, 2022, June 15, 2022, September 15, 2022 and December 15, 2022. In addition, we pay our non-management directors cash director fees of
$40,000  per  annum  ($10,000  per  quarter).  Non-management  directors  also  receive  additional  cash  compensation  on  an  annual  basis  for  serving  on  the  following  Board
committees:  The Audit  Committee  Chairperson  receives  $7,500  and  members  receive  $5,000;  the  Chairperson  and  members  of  each  of  the  Compensation  Committee  and
Nominating and Corporate Governance Committee receive annual fees of $3,750 and $2,500, respectively.

The following table sets forth the compensation awarded to, earned by or paid to all persons who served as members of our Board of Directors (other than our Named
Executive Officers) during the year ended December 31, 2022. No director who is also a Named Executive Officer received any compensation for services as a director in 2022.

Name

Emanuel Pearlman

Niv Harizman

Allison Hoffman

___________________________

Fees earned or
paid in cash ($)(1)
$50,000

$46,250

$48,185

Stock Awards
($)(2) (3)
$38,250

$38,250

$38,250

All other
compensation ($)(4)
$1,125

$   725

$1,125

Total
($)

$89,375

$85,250

$87,560

(1)

(2)

(3)

(4)

Represents directors’ fees payable in cash to each non-management director of $10,000 per quarter ($40,000 per annum) for 2022 plus additional cash fees for serving on
Board committees as disclosed above.

The amounts included in this column represent the grant date fair value of restricted stock unit awards (RSUs) granted to directors, computed in accordance with FASB
ASC Topic 718. For a discussion of valuation assumptions see Note B[10] to our consolidated financial statements included in this Annual Report. The 15,000 RSUs
granted to each non-management director vested on a quarterly basis beginning March 15, 2022. Each restricted stock unit represents the contingent right to receive one
share of common stock.

As of December 31, 2022, no stock options were owned by any of the above listed directors.

Includes payment of dividends (dividend equivalent rights) on RSUs for 2022.

-41- 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outstanding Equity Awards at December 31, 2022

The following table sets forth information relating to outstanding equity awards consisting of unvested restricted stock units for each Named Executive Officer as of

December 31, 2022 (there were no outstanding stock options):

Option Awards

Stock Awards

Number of Securities
Underlying Unexercised
Options

Name

Exercisable

Unexercisable

Corey M. Horowitz

Chairman and CEO

Jonathan Greene

Executive Vice President

—

—

—

—

Option Exercise
Price ($)

Option
Expiration
Date

—

—

—

—

Equity incentive
plan awards:
Number of
unearned shares,
units or other rights
that have not vested

Equity incentive plan
awards: Market value of
unearned shares, units or
other rights that have not
vested(1) ($)

600,000(2)

$1,320,000

15,000(3)

$33,000

________________________________
(1)

In accordance with SEC rules, market value is based on $2.20 per share representing the closing price of our common stock on the last trading day of the year.

(2)

(3)

Represents  600,000  restricted  stock  units,  the  terms  of  the  vesting  of  such  restricted  stock  units  are  disclosed  on  page  39  under  “Employment  Agreements  -
Termination of Employment and Change-In-Control Arrangements.”

Represents 15,000 restricted stock units, which vested 7,500 restricted stock units on January 18, 2023 and will vest 7,500 restricted stock units on January 18, 2024,
subject to Mr. Greene’s continued employment.

-42- 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS

The following table sets forth information regarding the beneficial ownership of our common stock as of March 10, 2023 for (i) each of our directors, (ii) each of our
executive officers, (iii) each person known by us to be the beneficial owner of more than 5% of our outstanding shares of common stock, and (iv) all of our executive officers
and directors as a group.

NAME AND ADDRESS OF BENEFICIAL OWNER

Executive Officers and Directors: Corey M. Horowitz(3)

CMH Capital Management Corp.(4)

Niv Harizman(5)

Emanuel Pearlman(6)

Jonathan E. Greene(7)

Allison Hoffman(8)

Robert Mahan

All officers and directors as a group
(6 Persons)

5% Stockholders:

Steven D. Heinemann(9)

Goose Hill Capital LLC(10)

_____________________________________

* Less than 1%.

AMOUNT AND
NATURE
OF BENEFICIAL
OWNERSHIP (1)
(2)

PERCENTAGE
OF COMMON
STOCK
BENEFICIALLY
OWNED(2)

6,782,292  

2,291,372  

290,985  

117,059  

93,945  

79,311  

—  

7,363,592  

2,052,769  

1,467,636  

28.4%  

9.6%  

1.2%  

*  

*  

*  

—  

30.8%  

8.6%  

6.2%  

(1) Unless otherwise indicated, we believe that all persons named in the above table have sole voting and investment power with respect to all shares of our common stock
beneficially owned by them. Unless otherwise indicated the address for each listed beneficial owner is c/o Network-1 Technologies, Inc., 65 Locust Avenue, Third Floor,
New Canaan, Connecticut 06840.

(2) A person is deemed to be the beneficial owner of shares of common stock that can be acquired by such person within 60 days from March 10, 2023 upon the exercise of
stock options or restricted stock units that vest within such 60 day period. Each beneficial owner's percentage ownership is determined by assuming that all stock options
and restricted stock units held by such person (but not those held by any other person) and which are exercisable or vest within 60 days from March 10, 2023 have been
exercised or vested.  Assumes a base of 23,790,005 shares of our common stock outstanding as of March 10, 2023.

-43- 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(3)

(4)

(5)

(6)

(7)

(8)

(9)

Includes (i) 3,868,909 shares of common stock owned by Mr. Horowitz, (ii) 100,000 shares of common stock subject to restricted stock units that vest within 60 days of
March  10,  2023  (iii)  2,157,097  shares  of  common  stock  held  by  CMH  Capital  Management  Corp.,  an  entity  solely  owned  by  Mr.  Horowitz,  (iv)  134,275  shares  of
common stock owned by the CMH Capital Management Corp. Profit Sharing Plan, of which Mr. Horowitz is the trustee, (v) 67,470 shares of common stock owned by
Donna  Slavitt,  the  wife  of  Mr.  Horowitz,  (vi)  an  aggregate  of  452,250  shares  of  common  stock  held  by  two  trusts  and  a  custodian  account  for  the  benefit  of  Mr.
Horowitz’s three children, and (vii) 2,291 shares of common stock held by Horowitz Partners, a general partnership of which Mr. Horowitz is a partner. Does not include
500,000 restricted stock units owned by Mr. Horowitz that do not vest within 60 days of March 10, 2023.

Includes 2,157,097 shares of common stock owned by CMH Capital Management Corp. and 134,275 shares of common stock owned by CMH Capital Management Corp.
Profit Sharing Plan.  Corey M. Horowitz, by virtue of being the sole officer, director and shareholder of CMH Capital Management Corp. and the trustee of the CMH
Capital Management Corp. Profit Sharing Plan, has the sole power to vote and dispose of the shares of common stock owned by CMH Capital Management Corp. and the
CMH Capital Management Corp. Profit Sharing Plan.

Includes (i) 287,235 shares of common stock and (ii) 3,750 shares of common stock subject to restricted stock units that vest within 60 days of March 10, 2023. Does not
include 11,250 shares of common stock subject to restricted stock units owned by Mr. Harizman that do not vest within 60 days from March 10, 2023.

Includes (i) 113,309 shares of common stock and (ii) 3,750 shares of common stock subject to restricted stock units that vest within 60 days of March 10, 2023. Does not
include 11,250 shares of common stock subject to restricted stock units owned by Mr. Pearlman that do not vest within 60 days from March 10, 2023.

Includes 93,945 shares of common stock.  Does not include 22,500 shares of common stock subject to restricted stock units owned by Mr. Greene that do not vest within
60 days from March 10, 2023.

Includes (i) 75,561 shares of common stock and (ii) 3,750 shares of common stock subject to restricted stock units that vest within 60 days of March 10, 2023. Does not
include 11,250 shares of common stock subject to restricted stock units owned by Ms. Hoffman that do not vest within 60 days from March 10, 2023.

Includes 585,133 shares of common stock owned by Mr. Heinemann and 1,467,636 shares of common stock owned by Goose Hill Capital LLC. Goose Hill Capital LLC
is a limited liability company of which Mr. Heinemann is the sole member. Mr. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole
power to vote and dispose of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon Amendment No. 10
to Schedule 13G filed by Mr. Heinemann with the SEC on February 14, 2023.  The address for Mr. Heinemann is c/o Goose Hill Capital, LLC, 12378 Indian Road, North
Palm Beach, Florida 33408.

(10) Includes 1,467,636 shares of common stock. Steven D. Heinemann, by virtue of being the sole member of Goose Hill Capital LLC, has the sole power to vote and dispose
of the shares of common stock owned by Goose Hill Capital LLC. The aforementioned beneficial ownership is based upon Amendment No. 10 to Schedule 13G filed by
Mr. Heinemann with the SEC on February 14, 2023. The address for Goose Hill Capital LLC is 12378 Indian Road, North Palm Beach, Florida 33408.

-44- 

 
 
 
 
 
ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND DIRECTOR INDEPENDENCE

On June 1, 2022, we repurchased from Allison Hoffman, a director of the Company, 41,500 shares of its common stock at a purchase price of $2.42 per share for an

aggregate purchase price of $100,430.

Review, Approval or Ratification of Transactions with Related Persons

The Audit  Committee  has  responsibility  for  reviewing  and  approving  related-persons  transactions  in  accordance  with  its  charter. A  related  person  is  any  executive
officer, director, nominee for director or more than 5% stockholder of the Company, including immediate family members, and any entity owned or controlled by such persons.
In addition, pursuant to our Code of Ethics, all of our officers, directors and employees are to avoid conflicts of interest and to refrain from taking part or exercising influence in
any transaction in which such party’s personal interest may conflict with the best interest of the Company.  Except for provisions of the Audit Committee Charter, there are no
written procedures governing review of related-persons transactions.

Director Independence

Three  of  our  five  directors,  Emanuel  Pearlman,  Niv  Harizman  and  Allison  Hoffman,  are  considered  independent  directors  in  compliance  with  the  standard  of

independence in Section 803A(2) of the NYSE American LLC Company Guide. 

ITEM 14. PRINCIPAL ACCOUNTANT FEES AND SERVICES

Audit Fees

Marcum LLP, our independent registered public accounting firm as of October 11, 2022, billed us aggregate fees of $103,200 for the year ended December 31, 2022,
for the audit of our annual financial statements, review of our financial statements included in our Form 10-Q for the three months ended September 30, 2022 and for other
services in connection with statutory or regulatory filings. Friedman LLP, our independent registered public accounting firm until October 11, 2022, billed us aggregate fees of
$48,832 and $135,535 for the years ended December 31, 2022 and 2021, respectively, for the audit of our financial statements for 2021, review of our financial statements
included in our Form 10-Qs and for other services in connection with statutory and regulatory filings.

Tax Fees and Other Fees

Marcum LLP provided various tax and compliance services for which it billed us $30,320 for the year ended December 31, 2022. Friedman LLP provided various tax
and compliance services for which it billed us $3,271 and $22,890, respectively, for the years ended December 31, 2022 and December 31, 2021 which included preparation of
our tax returns. Marcum LLP and Friedman LLP did not render any other professional services other than those discussed above for 2022.

Audit Committee Pre-Approval Policies and Procedures

Our  audit  committee  charter  provides  that  our  audit  committee  must  comply  with  SEC  rules  to  maintain  auditor  independence  as  set  forth  in  Rule  2-01(c)(7)(i)  of
Regulation S-X. The Audit Committee has a policy to pre-approve all audit and permissible non-audit services to be provided by our independent registered public accounting
firm. All the services above were approved in advance by our Board of Directors. 

-45- 

 
 
 
NETWORK-1 TECHNOLOGIES, INC.

INDEX TO CONSOLIDATED FINANCIAL STATEMENTS

Reports of Independent Registered Public Accounting Firms (PCAOB Firm ID 688 and 711)

Consolidated Balance Sheets as of December 31, 2022 and 2021

Consolidated Statements of Operations and Comprehensive Income (Loss) for the years ended December 31, 2022 and 2021

Consolidated Statements of Changes in Stockholders' Equity for the years ended December 31, 2022 and 2021

Consolidated Statements of Cash Flows for the years ended December 31, 2022 and 2021

Notes to Consolidated Financial Statements

PAGE

F-1

F-3

F-4

F-5

F-6

F-7

-46- 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Shareholders and Board of Directors of
Network-1 Technologies, Inc

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheet of Network-1 Technologies, Inc. (the “Company”) as of December 31, 2022, the related consolidated statements
of operations and comprehensive (loss), changes in stockholders’ equity, and cash flows for the year ended December 31, 2022, and the related notes (collectively referred to as
the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022, and
the  results  of  its  operations  and  its  cash  flows  for  the  year  ended  December  31,  2022  in  conformity  with  accounting  principles  generally  accepted  in  the  United  States  of
America.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company’s financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with
respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the  Securities  and  Exchange  Commission  and  the
PCAOB.

We  conducted  our  audit  in  accordance  with  the  standards  of  the  PCAOB. Those  standards  require  that  we  plan  and  perform  the  audit  to  obtain  reasonable  assurance  about
whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an
audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the
purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe
that our audit provides a reasonable basis for our opinion.

Critical Audit Matters

Critical  audit  matters  are  matters  arising  from  the  current  period  audit  of  the  financial  statements  that  were  communicated  or  required  to  be  communicated  to  the  audit
committee  and  that:  (1)  relate  to  accounts  or  disclosures  that  are  material  to  the  financial  statements  and  (2)  involved  our  especially  challenging,  subjective,  or  complex
judgments. We determined that there are no critical audit matters.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2014 (such date takes into account the acquisition of certain assets of Friedman LLP by Marcum LLP effective September 1,
2022)

New York, New York
March 30, 2023

F-1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

To the Board of Directors and Stockholders
Network-1 Technologies, Inc.

Opinion on the Financial Statements

We have audited the accompanying consolidated balance sheet of Network-1 Technologies, Inc. and Subsidiary (the “Company”) as of December 31, 2021, and the related
consolidated statements of operations and comprehensive income, changes in stockholders’ equity and cash flows for the year ended December 31, 2021, and the related notes
(collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of
December 31, 2021, and the results of its operations and its cash flows for the year ended December 31, 2021, in conformity with accounting principles generally accepted in
the United States of America.

Basis for Opinion

These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our
audit. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with
respect  to  the  Company  in  accordance  with  the  U.S.  federal  securities  laws  and  the  applicable  rules  and  regulations  of  the  Securities  and  Exchange  Commission  and  the
PCAOB.

We  conducted  our  audit  in  accordance  with  the  standards  of  the  PCAOB. Those  standards  require  that  we  plan  and  perform  the  audit  to  obtain  reasonable  assurance  about
whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an
audit of its internal control over financial reporting. As part of our audit we are required to obtain an understanding of internal control over financial reporting but not for the
purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we express no such opinion.

Our audit included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that
respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audit also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe
that our audit provides a reasonable basis for our opinion.

/s/ Friedman LLP

We have served as the Company’s auditor from 2014 to 2022.

New York, New York
March 30, 2022

F-2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

CONSOLIDATED BALANCE SHEETS

December 31,

2022

2021

ASSETS:

CURRENT ASSETS:

Cash and cash equivalents
Marketable securities, at fair value
Prepaid taxes
Other current assets

Total Current Assets

OTHER ASSETS:

Patents, net of accumulated amortization
Equity investment
Convertible note investment
Operating leases right of use asset
Security deposits

Total Other Assets

TOTAL ASSETS

LIABILITIES AND STOCKHOLDERS’ EQUITY:

CURRENT LIABILITIES:

Accounts payable
Income taxes payable
Accrued contingency fees and related costs
Accrued payroll
Other accrued expenses
Operating lease obligations, current

Total Current Liabilities

LONG TERM LIABILITIES:

Deferred tax liability
Operating lease obligation, non-current

TOTAL LIABILITIES

COMMITMENTS AND CONTINGENCIES (See Note I)

STOCKHOLDERS' EQUITY

Preferred stock, $0.01 par value; authorized 10,000,000 shares;

none issued and outstanding at December 31, 2022 and December 31, 2021

Common stock, $0.01 par value; authorized 50,000,000 shares;

23,863,639 and 23,792,212 shares issued and outstanding at December 31, 2022 and
December 31, 2021, respectively

Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss

TOTAL STOCKHOLDERS’ EQUITY

$

$

$

13,448,000   
34,991,000   
177,000   
348,000   

48,964,000   

1,592,000   
7,252,000   
—   
161,000   
—   

9,005,000   

57,969,000   

507,000   
115,000   
—   
317,000   
587,000   
79,000   

1,605,000   

1,161,000   
94,000   

$

$

$

44,497,000 
15,126,000 
— 
150,000 

59,773,000 

1,384,000 
2,651,000 
1,000,000 
— 
13,000 

5,048,000 

64,821,000 

459,000 
2,952,000 
137,000 
380,000 
180,000 
— 

4,108,000 

554,000 
— 

$

2,860,000   

$

4,662,000 

—   

— 

239,000   

66,939,000   
(12,055,000)  
(14,000)  

55,109,000   

238,000 

66,361,000 
(6,428,000)
(12,000)

60,159,000 

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$

57,969,000   

$

64,821,000 

The accompanying notes are an integral part of the consolidated financial statements 

F-3

 
 
 
 
 
    
 
  
 
 
 
 
 
   
 
 
    
  
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
    
 
  
 
 
    
 
  
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS)

REVENUE

OPERATING EXPENSES:

Costs of revenue
Professional fees and related costs
General and administrative
Amortization of patents

TOTAL OPERATING EXPENSES

OPERATING INCOME (LOSS)

OTHER INCOME

Interest and dividend income, net
Gain on conversion of note
Gain on equity method investment
Net realized and unrealized loss on marketable securities
Total other income, net

Years Ended
December 31,

2022

2021

$

—   

$

36,029,000 

—   
809,000   
2,778,000   
316,000   

3,903,000   

(3,903,000)  

1,020,000   
271,000   
3,883,000   
(1,351,000)  
3,823,000   

12,147,000 
1,500,000 
2,501,000 
295,000 

16,443,000 

19,586,000 

327,000 
— 
— 
(173,000)
154,000 

(LOSS) INCOME BEFORE INCOME TAXES AND SHARE OF NET LOSSES OF
EQUITY METHOD INVESTEE

(80,000)  

19,740,000 

INCOME TAXES PROVISION:

Current
Deferred taxes, net
Total income taxes expense

(LOSS) INCOME BEFORE SHARE OF NET LOSSES OF
EQUITY METHOD INVESTEE:

SHARE OF NET LOSSES OF EQUITY METHOD INVESTEE

NET (LOSS) INCOME

Net (Loss) Income Per Share:

Basic

Diluted

Weighted average common shares outstanding:

Basic
Diluted

Cash dividends declared per share

NET (LOSS) INCOME

OTHER COMPREHENSIVE LOSS

Net unrealized holding loss on corporate bonds and notes
arising during the year, net of tax

COMPREHENSIVE (LOSS) INCOME

—   
607,000   
607,000   

(687,000)  

 (1,639,000)  

(2,326,000)  

(0.10)  
(0.10)  

23,825,917   
23,825,917   

0.10   

(2,326,000)  

(2,000)  

(2,328,000)  

$

$
$

$

$

$

The accompanying notes are an integral part of the consolidated financial statements 

2,952,000 
1,508,000 
4,460,000 

15,280,000 

 (999,000)

14,281,000 

0.59 
0.58 

24,136,821 
24,530,568 

0.10 

14,281,000 

(2,000)

14,279,000 

F-4

$

$
$

$

$

$

 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
   
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
    
 
  
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

 CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY
FOR THE YEARS ENDED DECEMBER 31, 2022 AND 2021

Common Stock

Shares

  Amount

  24,105,879    $

—   
—   
70,000   
(5,192)  
(378,475)  
—   
—   

  23,792,212    $

—   
—   
182,500   
500,000   

241,000    $
—   
—   
1,000   
—   
(4,000)  
—   
—   
238,000    $
—   
—   
2,000   
5,000   

Additional
Paid-in
Capital

Accumulated
Deficit

Accumulated
Other
Comprehensive
(Loss)

 Total
Stockholders’
Equity

Total
Stockholders’
Equity

66,124,000    $ (17,193,000)   $

—   
238,000   
(1,000)  
—   
—   
—   
—   

(2,429,000)  
—   
—   
(14,000)  
(1,073,000)  
—   
14,281,000   

66,361,000    $ (6,428,000)   $

—   
585,000   
(2,000)  
(5,000)  

(2,418,000)  
—   
—   
—   

(352,000)  
(531,000)  
—   
(2,326,000)  

—   
—   
—   
—   
—   
(2,000)  
—   

(10,000)   $ 49,162,000 
(2,429,000)
238,000 
— 
(14,000)
(1,077,000)
(2,000)
14,281,000 
(12,000)   $ 60,159,000 
(2,418,000)
585,000 
— 
— 

—   
—   
—   
—   

—   
—   
(2,000)  
                  —   

(355,000)
(534,000)
(2,000)
(2,326,000)
(14,000)   $ 55,109,000 

(382,543)  
(228,530)  
—   
                  —   
  23,863,639    $

(3,000)  
(3,000)  
—   
                 —   

—   
—   
—   
                      —   

239,000    $

66,939,000    $ (12,055,000)   $

Balance – January 1, 2021
Dividends and dividend equivalents declared
Stock-based compensation
Vesting of restricted stock units
Value of shares delivered to pay withholding taxes
Treasury stock purchased and retired
Net unrealized loss on corporate bonds and notes
Net income
Balance – December 31, 2021
Dividends and dividend equivalents declared
Stock-based compensation
Vesting of restricted stock units
Cashless exercise of stock options
Value of shares delivered to pay exercise price and
withholding taxes
Treasury stock purchased and retired
Net unrealized loss on corporate bonds and notes
Net loss

Balance – December 31, 2022

The accompanying notes are an integral part of the consolidated financial statements

F-5

 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
    
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

Years Ended
              December 31,            

2022

2021

$

(2,326,000)  

$

14,281,000 

CASH FLOWS FROM OPERATING ACTIVITIES:

Net (loss) income
Adjustments to reconcile net (loss) income to net cash
used in operating activities:
Amortization of patents
Stock-based compensation
Loss allocated from equity investment
Deferred tax expense
Amortization of right of use asset, net
Gain on equity method investment
Accrued interest on convertible note
Gain on conversion of note
Unrealized loss on marketable securities

Changes in operating assets and liabilities:

Other current assets
Prepaid taxes
Accounts payable
Income taxes payable
Security deposit
Operating lease obligations
Accrued expenses

NET CASH (USED IN) PROVIDED BY OPERATING ACTIVITIES

CASH FLOWS FROM INVESTING ACTIVITIES:

Sales of marketable securities
Purchases of marketable securities
Development of patents
Equity Investment
Convertible note investment

NET CASH (USED IN) PROVIDED BY INVESTING ACTIVITIES

CASH FLOWS FROM FINANCING ACTIVITIES:

Cash dividends paid
Value of shares delivered to fund withholding taxes
Repurchases of common stock, inclusive of commissions

NET CASH USED IN FINANCING ACTIVITIES

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS, beginning of year

CASH AND CASH EQUIVALENTS, end of year

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

Cash paid during the years for:

Interest
Income taxes

NON-CASH FINANCING ACTIVITY

Accrued dividend rights on restricted stock units
Right of use asset obtained in exchange for lease liability
Conversion of note receivable

316,000   
585,000   
1,639,000   
607,000   
43,000   
(3,883,000)  
(86,000)  
(271,000)  
880,000   

(208,000)  
(167,000)  
48,000   
(2,837,000)  
13,000   
(31,000)  
242,000   

(5,436,000)  

13,156,000   
(33,903,000)  
(524,000)  
(1,000,000)  
—   

(22,271,000)  

(2,453,000)  
(355,000)  
(534,000)  

(3,342,000)  

(31,049,000)  

44,497,000   

13,448,000   

     —   
3,004,000   

37,000   
204,000   
1,086,000   

$

$
$

$
$
$

295,000 
238,000 
999,000 
1,508,000 
— 
— 
— 
— 
148,000 

(30,000)
— 
(142,000)
2,952,000 
8,000 
— 
(758,000)

19,499,000 

17,154,000 
(13,059,000)
(101,000)
— 
(1,000,000)

2,994,000 

(2,410,000)
(14,000)
(1,077,000)

(3,501,000)

18,992,000 

25,505,000 

44,497,000 

— 
— 

20,000 
— 
— 

F-6

$

$
$

$

The accompanying notes are an integral part of the consolidated financial statements

 
 
 
 
 
 
    
 
  
 
 
 
 
 
   
 
 
 
    
 
  
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
    
 
  
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC. 

NOTE A – BUSINESS

Network-1 Technologies, Inc. (the “Company”) is engaged in the development, licensing and protection of its intellectual property assets. The Company presently owns
ninety-seven (97) U.S. patents, fifty-two (52) of such patents have expired, and eight (8) foreign patents related to (i) the Cox patent portfolio (the “Cox Patent Portfolio)
relating to enabling technology for identifying media content on the Internet and taking further actions to be performed after such identification; (ii) the M2M/IoT patent
portfolio (the “M2M/IoT Patent Portfolio”) relating to, among other things, enabling technology for authenticating, provisioning and using embedded SIM (Subscriber
Identification Module)technology in next generation IoT, Machine-to-Machine, and other mobile devices, including smartphones, tablets and computers; (iii) the HFT
patent  portfolio  (the  “HFT  Patent  Portfolio”)  covering  certain  advanced  technologies  relating  to  high  frequency  trading,  which  inventions  specifically  address
technological problems associated with speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be
measured in nanoseconds; (iv) the Mirror Worlds patent portfolio (the “Mirror Worlds Patent Portfolio”) relating to foundational technologies that enable unified search
and indexing, displaying and archiving of documents in a computer system; and (v) the remote power patent (the “Remote Power Patent”) covering delivery of Power
over Ethernet (PoE) cables for the purpose of remotely powering network devices, such as wireless access ports, IP phones and network based cameras.

The Company’s current strategy includes continuing to pursue licensing opportunities for its intellectual property assets. In addition, the Company continually reviews
opportunities to acquire or license additional intellectual property as well as other strategic alternatives. The Company’s patent acquisition and development strategy is to
focus on acquiring high quality patents which management believes have the potential to generate significant licensing opportunities as the Company has achieved with
respect to its Remote Power Patent and Mirror Worlds Patent Portfolio. In addition, the Company may also enter into strategic relationships with third parties to develop,
commercialize, license or otherwise monetize their intellectual property.

The Company has made equity investments totaling $7,000,000 in ILiAD Biotechnologies, LLC (“ILiAD”), a clinical stage biotechnology company (see Note H hereof).

NOTE B – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

[1]

Principles of Consolidation

The  Company’s  consolidated  financial  statements  have  been  prepared  in  accordance  with  accounting  principles  generally  accepted  in  the  United  States  of America
(“U.S. GAAP”). The accompanying financial statements include the accounts of the Company and its wholly-owned subsidiaries, Mirror Worlds Technologies, LLC and
HFT Solutions, LLC. All intercompany transactions and balances are eliminated in consolidation.

[2] Use of Estimates and Assumptions

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported
amounts  of  assets  and  liabilities  and  disclosure  of  contingent  assets  and  liabilities  at  the  date  of  the  consolidated  financial  statements,  and  the  reported  amounts  of
revenues  and  expenses  during  the  reporting  periods.  The  significant  estimates  and  assumptions  made  in  the  preparation  of  the  Company’s  consolidated  financial
statements  primarily  include  costs  related  to  the  Company’s  assertion  of  litigation,  the  valuation  of  the  Company’s  patent  portfolios,  stock-based  compensation,  the
recoverability of deferred tax assets and carrying value of the Company’s equity method investments. Actual results could be materially different from those estimates,
upon which the carrying values were based.

Certain  amounts  recorded  to  reflect  the  Company’s  share  of  income  or  losses  of  its  equity  method  investee,  accounted  for  under  the  equity  method,  are  based  on
estimates  and  the  unaudited  results  of  operations  of  the  equity  method  investee  and  may  require  adjustment  in  the  future  when  the  audit  is  complete. The  Company
reports its share of the results of its equity method investee on a one quarter lag basis.

F-7

 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC. 

NOTE B – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

[3] Cash and Cash Equivalents

The Company maintains cash deposits in high quality financial institutions insured by the Federal Deposit Insurance Corporation ("FDIC"). Accounts at each institution
are insured by the FDIC up to $250,000. At December 31, 2022 and 2021, the Company had $1,715,000 and $8,109,000, respectively, in excess of the FDIC insured
limit.

The Company considers all highly liquid short-term investments, including certificates of deposit and money market funds, that are purchased with an original maturity
of three months or less to be cash equivalents.

[4] Marketable Securities

The  Company’s  marketable  securities  are  comprised  of  certificates  of  deposit  with  original  maturity  greater  than  three  months  from  date  of  purchase,  government
securities,  fixed  income  mutual  funds,  and  a  corporate  bond  (see  Note  G).  At  December  31,  2022  and  December  31,  2021,  included  in  marketable  securities,  the
Company had aggregate certificates of deposit of $2,976,000 and $0, respectively. The Company’s marketable securities are measured at fair value and are accounted for
in accordance with ASU 2016-01. Unrealized holding gains and losses on certificates of deposit, government securities, and fixed income mutual funds are recorded in
net realized and unrealized gain (loss) from investments on the consolidated statements of operations and comprehensive income (loss). Unrealized holding gains and
losses,  net  of  the  related  tax  effect,  on  corporate  bonds  and  notes  are  excluded  from  earnings  and  are  reported  as  a  separate  component  of  stockholders’  equity  until
realized. Dividend and interest income are recognized when earned. Realized gains and losses are included in earnings and are derived using the specific identification
method for determining the cost of the marketable securities.

[5] Revenue Recognition

Under ASC 606, revenue is recognized when the Company completes the licensing of its intellectual property to its licensees, in an amount that reflects the consideration
the Company expects to be entitled to in exchange for licensing its intellectual property.

The Company determines revenue recognition through the follow steps:

•
•
•
•
•

identification of the license agreement;
identification of the performance obligations in the license agreement;
determination of the consideration for the license;
allocation of the transaction price to the performance obligations in the contract; and
recognition of revenue when the Company satisfies its performance obligations.

Revenue disaggregated by source is as follows (the Company had no revenue for the year ended December 31, 2022):

Fully-Paid Licenses
Royalty Bearing Licenses
Total Revenue

Years Ended December 31,

2022

—   
—   
—   

$

$

2021

17,000,000(1)
19,029,000(2)
36,029,000 

$

$

__________________________
(1)

Includes $17,000,000 received from Hewlett-Packard related to settlement of a patent litigation (see Note K[1] hereof).

(2)

Includes (1) $18,691,890 of royalty revenue from Cisco Systems, Inc. from resolution of a dispute under its license agreement with the Company and (2) $337,000 of royalty revenue
received from Plantronics, Inc.

F-8

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
   
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE B – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

Revenue from the Company’s patent licensing business is typically generated from negotiated license agreements. The timing and amount of revenue recognized from
each licensee depends upon a variety of factors, including the terms of each agreement and the nature of the obligations of the parties. These agreements may include, but
not be limited to, elements related to past infringement liabilities, non-refundable upfront license fees, and ongoing royalties on licensed products sold by the licensee.
Generally, in the event of settlement of litigation related to the Company’s assertion of patent infringement involving its intellectual property, defendants will either pay
(i)  a  non-refundable  lump  sum  payment  for  a  non-exclusive  fully-paid  license,  or  (ii)  a  non-refundable  lump  sum  payment  (license  initiation  fee)  together  with  an
ongoing obligation to pay quarterly or monthly royalties to the Company for the life of the licensed patent.

[6]

Equity Method Investments

Equity  method  investments  are  equity  securities  in  entities  the  Company  does  not  control  but  over  which  it  has  the  ability  to  exercise  significant  influence.  These
investments are accounted for under the equity method of accounting in accordance with ASC 323, Investments — Equity Method and Joint Ventures (see Note H hereof).
Equity  method  investments  are  measured  at  cost  minus  impairment,  if  any,  plus  or  minus  the  Company’s  share  of  an  investee’s  income  or  loss.  The  Company’s
proportionate share of the income or loss from equity method investments is recognized on a one-quarter lag. When the Company’s carrying value in an equity method
investment is reduced to zero, no further losses are recorded in the Company’s financial statements unless the Company guaranteed obligations of the investee company
or has committed additional funding. When the investee company subsequently reports income, the Company will not record its share of such income until it equals the
amount of its share of losses not previously recognized.

Upon a sale of an equity method investment by the Company, the difference between sales proceeds and the carrying amount of the equity investment is recognized in
profit or loss. Upon the issuance of securities in an observable price transaction, the Company will account for the share issuance by the equity method investee as if the
Company had sold a proportionate share of its investment in the observable price transaction. The Company will record a gain or loss associated with the dilution of its
investment to reflect third party investments in the investee and will increase or decrease its basis in the equity method investee accordingly. The gain or loss is recorded
within other income or expense in the Company’s consolidated statements of operations and comprehensive income (loss).

During the year ended December 31, 2022, the Company recorded a change in its share of net losses of the equity method investee as a result of the Company receiving
new information from the equity method investee during the fourth quarter of 2022. The effect of this change was an increase in the Company’s share of the net losses of
the equity method investee of $398,000 and a corresponding decrease in the Company’s net income, and a decrease in basic and diluted earnings of $0.02 per share.

The Company performed an assessment to determine significance of the equity method investee under the investment, asset and income tests utilizing the 20% threshold.
The Company determined that the equity method investee satisfied the income test and has included summarized financial data of the equity method investee in Note H
hereof.

[7]

Patents

The  Company  owns  patents  that  relate  to  various  technologies.  The  Company  capitalizes  the  costs  associated  with  acquisition,  registration  and  maintenance  of  its
acquired  patents  and  amortizes  these  assets  over  their  remaining  useful  lives  on  a  straight-line  basis. Any  further  payments  made  to  maintain  or  develop  the  patents
would be capitalized and amortized over the balance of the useful life for the patents.

[8] Costs of Revenue and Related Costs

The  Company  includes  in  costs  of  revenue  for  the  year  ended  December  31,  2022  and  2021  contingent  legal  fees  payable  to  patent  litigation  counsel,  any  other
contractual  payments  to  third  parties  related  to  net  proceeds  from  monetization  of  patents  (see  Note  I[1]  hereof)  and  incentive  bonus  compensation  payable  to  its
Chairman and Chief Executive Officer (see Note J[1] hereof).

F-9

 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE B – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

[9]

Income Taxes

The Company accounts for income taxes in accordance with Financial Accounting Standards Board (FASB) ASC Topic 740, Income Taxes (ASC 740), which requires
the Company to use the assets and liability method of accounting for income taxes. Under the assets and liability method, deferred income taxes are recognized for the
tax consequences of temporary (timing) differences by applying enacted statutory tax rates applicable to future years to differences between financial statement carrying
amounts and the tax bases of existing assets and liabilities and operating loss and tax credit carry forwards. Under this accounting standard, the effect on deferred income
taxes of a change in tax rates is recognized in income in the period that includes the enactment date. A valuation allowance is recognized if it is more likely than not that
some portion, or all, of a deferred tax asset will not be realized.

ASC 740-10, Accounting for Uncertainty in Income Taxes, defines uncertainty in income taxes and the evaluation of a tax position as a two-step process. The first step is
to determine whether it is more likely than not that a tax position will be sustained upon examination, including the resolution of any related appeals or litigation based
on the technical merits of that position. The second step is to measure a tax position that meets the more-likely-than-not threshold to determine the amount of benefit to
be recognized in the financial statements. A tax position is measured at the largest amount of benefit that is greater than 50 percent likelihood of being realized upon
ultimate settlement. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first subsequent period in
which  the  threshold  is  met.  Previously  recognized  tax  positions  that  no  longer  meet  the  more-likely-than-not  criteria  should  be  de-recognized  in  the  first  subsequent
financial reporting period in which the threshold is no longer met. The Company had no uncertain tax positions as of December 31, 2022 and 2021.

U.S. federal, state and local income tax returns prior to 2019 are not subject to examination by any applicable tax authorities, except that tax authorities could challenge
returns (only under certain circumstances) for earlier years to the extent they generated loss carry-forwards that are available for those future years.

[10] Stock-Based Compensation

The  Company  accounts  for  its  stock-based  compensation  awards  to  employees  and  directors  in  accordance  with  FASB  ASC  Topic  718,  Compensation  —  Stock
Compensation (“ASC 718”). ASC 718 requires all stock-based compensation to employees, including grants of employee stock options and restricted stock units, to be
recognized in the consolidated statements of operations and comprehensive income (loss) based on their grant date fair values.

Compensation expense related to awards to employees is recognized on a straight-line basis based on the grant date fair value over the associated service period of the
award, which is generally the vesting term. The Company uses the Black-Scholes option pricing model to determine the grant date fair value of options granted. The fair
value of restricted stock units is determined based on the number of shares underlying the grant and either the quoted market price of the Company’s common stock on
the date of grant for time-based and performance-based awards, or the fair value on the date of grant using the Monte Carlo Simulation model for market-based awards.

[11] Earnings Per Share

The  Company  reports  earnings  per  share  in  accordance  with  U.S.  GAAP,  which  requires  presentation  of  basic  and  diluted  earnings  per  share  in  conjunction  with  the
disclosure of the methodology used in computing such earnings per share. Basic earnings per share excludes dilution and is computed by dividing income available to
common shareholders by the weighted average common shares outstanding during the period. Diluted earnings per share takes into account the potential dilution that
could  occur  if  securities  or  other  contracts,  such  as  warrants  and  options  to  purchase  common  stock  were  exercised  and  shares  were  issued  pursuant  to  outstanding
restricted stock units. Common stock equivalents having an anti-dilutive effect on earnings per share are excluded from the calculation of diluted earnings per share.

F-10

 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE B – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

[12] Fair Value Measurements

ASC Topic 820, Fair Value Measurement and Disclosures, defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an
exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. This
topic also establishes a fair value hierarchy which requires classification based on observable and unobservable inputs when measuring fair value.

There are three levels of inputs that may be used to measure fair value:

Level 1: Observable inputs such as quoted prices (unadjusted) in an active market for identical assets or liabilities.

Level 2: Inputs other than quoted prices that are observable, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets and
quoted prices for identical or similar assets or liabilities in markets that are not active.

Level 3: Unobservable inputs that are supported by little or no market activity; therefore, the inputs are developed by the Company using estimates and assumptions that
the Company expects a market participant would use, including pricing models, discounted cash flow methodologies, or similar techniques.

The carrying value of the Company’s financial instruments, including cash and cash equivalents and accounts payable, approximates fair value because of the short-term
nature of these financial instruments.

The Company’s marketable securities are classified within Level 1 because they are valued using quoted market prices in an active market.

The Company’s equity method investment is measured on a non-recurring basis and is classified within Level 2 as it is valued using an observable price transaction for
similar assets in a market that is not active (see Note B[6] and Note H hereof).

[13] Carrying Value, Recoverability and Impairment of Long-Lived Assets

An impairment loss shall be recognized only if the carrying amount of a long-lived asset (asset group) is not recoverable and exceeds its fair value. The carrying amount
of a long-lived asset (asset group) is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the
asset (asset group). That assessment shall be based on the carrying amount of the asset (asset group) at the date it is tested for recoverability. An impairment loss shall be
measured as the amount by which the carrying amount of a long-lived asset (asset group) exceeds its fair value. If an impairment loss is recognized, the adjusted carrying
amount of a long-lived asset shall be its new cost basis. For a depreciable long-lived asset, the new cost basis shall be depreciated (amortized) over the remaining useful
life  of  that  asset.  Restoration  of  a  previously  recognized  impairment  loss  is  prohibited. At  December  31,  2022  and  2021,  there  was  no  impairment  to  the  Company’s
patents and equity investment.

The Company’s equity investment in ILiAD is evaluated on a non-recurring basis for impairment, when and if a triggering event occurs.

F-11

 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC. 

NOTE B – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)

[14] Leases

Under  ASC  842,  the  Company  determines  if  an  arrangement  is  a  lease  at  inception.  Right-of-Use  (“ROU”)  assets  and  related  lease  obligations  are  recognized  at
commencement date based on the present value of remaining lease payments over the lease term. For this purpose, the Company considers only payments that are fixed
and determinable at the time of commencement. As the Company's lease does not provide an implicit rate, the Company uses its incremental borrowing rate based on the
information available at commencement date in determining the present value of lease payments. The Company's determined incremental borrowing rate is a hypothetical
rate based on its understanding of what the Company's credit rating would be. The ROU asset also includes any lease payments made prior to commencement and is
recorded  net  of  any  lease  incentives  received  and  net  of  the  deferred  rent  balance  on  the  date  of  implementation. The  Company's  lease  terms  may  include  options  to
extend or terminate the lease when it is reasonably certain that it will exercise such options. As permitted under ASC 842, the Company has elected to not recognize ROU
assets and related lease obligations for leases with terms of twelve months or less.

[15] Dividend Policy

Cash dividends are recorded when declared by the Company’s Board of Directors. Common stock dividends are charged against retained earnings when declared or paid
(see Note O hereof).

[16] Reclassifications

Stock-based compensation in the 2021 consolidated statements of operations and comprehensive income (loss) have been recast and reclassified to conform to the current
year’s presentation. 

NOTE C – PATENTS

The Company’s intangible assets at December 31, 2022 include patents with estimated remaining economic useful lives ranging from 0.50 to 16.50 years. For all periods
presented, all the Company’s patents were subject to amortization. The gross carrying amounts and accumulated amortization related to acquired intangible assets as of
December 31, 2022 and 2021 were as follows:

Gross carrying amount
Accumulated amortization
Patents, net

2022

8,473,000   
(6,881,000)  
1,592,000   

$

$

2021

7,949,000 
(6,565,000)
1,384,000 

$

$

Amortization expense for the years ended December 31, 2022 and 2021 was $316,000 and $295,000, respectively. Future amortization of current intangible assets, net is
as follows:

For the years ended December 31,
2023
2024
2025
2026
2027
Thereafter
Total

$

$

266,000 
120,000 
120,000 
120,000 
119,000 
847,000 
1,592,000 

Two patents within the Cox Patent Portfolio expire in July 2023 and November 2023, and the balance of the patents within such portfolio have expired. The expiration
dates  of  patents  within  the  Company’s  M2M/IoT  Patent  Portfolio  range  from  September  2033  to  May  2034. The  expiration  dates  within  the  Company’s  HFT  Patent
Portfolio range from October 31, 2039 to November 1, 2039. All of the patents within the Company’s Mirror Worlds Patent Portfolio expired and the Remote Power
Patent expired.

F-12

 
 
 
 
 
 
 
 
 
    
 
  
 
 
   
 
 
 
 
 
 
 
   
 
  
   
  
   
   
 
   
 
   
 
   
 
   
 
   
 
   
 
  
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE D – INCOME (LOSS) PER SHARE

Basic Income (Loss) per share is calculated by dividing the net income (loss) by the weighted average number of outstanding common shares during the period. Diluted
per share data included the dilutive effects of stock options and restricted stock units. Potentially dilutive shares of 625,000 and 12,500 at December 31, 2022 and 2021,
respectively, consist of restricted stock units. However, as the Company generated a net loss in 2022, all potentially dilutive shares were not reflected in diluted net loss
per share because the impact of such instruments was anti-dilutive. Computations of basic and diluted weighted average common shares outstanding are as follows:

2022

2021

Weighted-average common shares outstanding – basic

23,825,917   

24,136,821 

Dilutive effect of restricted stock units and stock options

— 

393,747 

Weighted-average common shares outstanding – diluted

23,825,917   

24,530,568 

Restricted stock units excluded from the computation of diluted income per
share because the effect of inclusion would have been anti-dilutive

625,000   

12,500 

NOTE E – INCOME TAXES

Significant components of the income taxes were as follows for the years ended December 31, 2022 and 2021.

Current

State and local
Federal

Total Current Tax Expense (Benefit)

Deferred

State and local
Federal

Total Deferred Tax Expense

Total Income Taxes

2022

2021

$

$

—   
—   
—   

$

$

144,000 
2,808,000 
2,952,000 

   56,000   
551,000   
607,000   

83,000 
1,425,000 
1,508,000 

$

607,000   

$

4,460,000 

Significant components of deferred tax assets (liability) as of December 31, 2022 and 2021 consisted of the following:

Deferred tax assets (liability):
         Net operating loss carryforward
         Capital loss carryforward
         Stock options and RSU
Valuation allowance

        Deferred Tax Liability(1)
Total deferred tax liability

2022

2021

$

$

477,000   
331,000   
30,000   
(838,000)

(1,161,000)  
(1,161,000)  

$

$

— 
— 
— 
—

(554,000)
(554,000)

_________________________
(1) Deferred tax liability primarily as a result of a temporary difference related to the Company’s equity method investment.

F-13

 
 
 
 
 
 
 
 
    
 
  
 
 
   
 
 
 
 
   
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
    
 
  
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
    
 
  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
    
 
  
 
 
   
 
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
    
 
  
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE E – INCOME TAXES (CONTINUED) 

As  of  December  31,  2022,  the  Company’s  estimated  aggregate  total  net  operating  loss  carryforwards  (NOLs)  were  $2,168,000  for  U.S.  federal  tax  purposes  with  an
indefinite life.  At December 31, 2022, the Company had deferred tax assets of $838,000, which were offset by a valuation allowance of $838,000 as it was determined
that it is more likely than not that the deferred tax assets would not be realized. At December 31, 2022, the Company had a deferred tax liability position of $1,161,000.

The reconciliation between the taxes as shown and the amount that would be computed by applying the statutory federal income tax rate to the net income before income
taxes is as follows:

Income tax - statutory rate
Permanent differences
Change in valuation allowance
State
Other

  Total

Years Ended
December 31,

2022

2021

21.00%   
(8.40)%   
(48.79)%   
1.28%   
(0.43)%   
(35.34)%   

21.00% 
1.69% 
—% 
1.11% 
—% 
23.80% 

On August 16, 2022, the Inflation Reduction Act of 2022 (the “IR Act”) was signed into federal law. The IR Act provides for, among other things, a new U.S. federal 1%
excise tax on certain repurchases of stock by publicly traded U.S. domestic corporations and certain U.S. domestic subsidiaries of publicly traded foreign corporations
occurring  on  or  after  January  1,  2023. The  excise  tax  is  imposed  on  the  repurchasing  corporation  itself,  not  its  shareholders  from  which  shares  are  repurchased. The
amount of the excise tax is generally 1% of the fair market value of the shares repurchased at the time of the repurchase. However, for purposes of calculating the excise
tax, repurchasing corporations are permitted to net the fair market value of certain new stock issuances against the fair market value of stock repurchases during the same
taxable year. In addition, certain exceptions apply to the excise tax. The U.S. Department of Treasury has been given authority to provide regulations and other guidance
to carry out and prevent the abuse or avoidance of the excise tax. The excise tax applies in cases where the total value of the stock repurchased during the taxable year
exceeds $1,000,000.

The  personal  holding  company  (“PHC”)  rules  under  the  Internal  Revenue  Code  impose  a  20%  tax  on  a  PHC’s  undistributed  personal  holding  company  income
(“UPHCI”), which means, in general, taxable income subject to certain adjustments. For a corporation to be classified as a PHC, it must satisfy two tests: (i) that more
than 50% in value of its outstanding shares must be owned directly or indirectly by five or fewer individuals at any time during the second half of the year (after applying
constructive ownership rules to attribute stock owned by entities to their beneficial owners and among certain family members and other related parties) (the “Ownership
Test”)  and  (ii)  at  least  60%  of  its  adjusted  ordinary  gross  income  for  a  taxable  year  consists  of  dividends,  interest,  royalties,  annuities  and  rents  (the  “Income Test”).
During the second half of 2022, based on available information concerning the Company’s shareholder ownership, the Company did not satisfy the Ownership Test and
thus  the  Company  was  not  a  PHC  for  2022.  However,  the  Company  may  subsequently  be  determined  to  be  a  PHC  in  2023  or  in  future  years  if  it  satisfies  both  the
Ownership Test and the Income Test. If the Company were to become a PHC in any future year, it would be subject to an additional 20% tax on its UPHCI. In such event,
the Company may issue a special cash dividend, to its shareholders in an amount equal to the UPHCI rather than incur the additional 20% tax.

F-14

 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC. 

NOTE F – STOCKHOLDERS’ EQUITY

The Company adopted a new 2022 Stock Incentive Plan, (the “2022 Plan”), approved by its Board of Directors on July 25, 2022 and its stockholders on September 20,
2022. The 2022 Plan provides for the grant of any or all of the following types of awards: (a) stock options, (b) restricted stock, (c) deferred stock, (d) stock appreciation
rights, and (e) other stock-based awards including restricted stock units. Awards under the 2022 Plan may be granted singly, in combination, or in tandem. Subject to
standard  anti-dilution  adjustments  as  provided,  the  2022  Plan  provides  for  an  aggregate  of  2,300,000  shares  of  the  Company’s  common  stock  to  be  available  for
distribution. The Company’s Compensation Committee generally has the authority to administer the 2022 Plan, determine participants who will be granted awards, the
size and types of awards, the terms and conditions of awards and the form and content of the award agreements representing awards. Awards under the 2022 Plan may be
granted to employees, directors and consultants of the Company and its subsidiaries. As of December 31, 2022, there were 2,300,000 shares of common stock available
for issuance under the 2022 Plan.

As of December 31, 2022, there were 625,000 shares of common stock subject to outstanding awards under the Company 2013 Stock Incentive Plan (“2013 Plan”). The
Company discontinued issuing awards under its 2013 Plan as a result of the adoption of the 2022 Plan.

[1] Restricted Stock Units

A summary of restricted stock units granted during the years ended December 31, 2022 and December 31, 2021 is as follows (each restricted stock unit represents the
contingent right to receive one share of the Company’s common stock):

Balance of restricted stock units outstanding at beginning of year
Grants of restricted stock units
Vested restricted stock units
Balance of restricted stock units outstanding at end of year

2022

2021

Number of
Shares

12,500   
670,000   
(57,500)  
625,000   

Weighted-Average
Grant

Date Fair Value    
3.36   
1.92   
(2.73)  
1.87   

$

$

Number of
Shares

162,500   
45,000   
(195,000)  
12,500   

$

Weighted-Average
Grant
Date Fair Value  
2.25 
3.51 
(2.47)
3.36 

$

Restricted stock unit compensation expense was $585,000 for the year ended December 31, 2022 and $238,000 for the year ended December 31, 2021.

The  Company  has  an  aggregate  of  $736,000  of  unrecognized  restricted  stock  unit  compensation  expense  as  of  December  31,  2022  to  be  expensed  over  a  weighted
average period of 2.61 years.

The fair value of restricted stock units is determined based on the number of shares granted and the quoted market price of the Company’s common stock on the date of
grant for time-based and performance-based awards and fair value at grant date using the Monte Carlo simulation model for market-based awards. The key inputs into the
Monte Carlo simulation used to value the restricted stock units was a risk-free rate of 2.39%, expected term of 4 years, expected volatility of 40% and a stock price of
$2.47.

All  of  the  Company’s  issued  restricted  stock  units  have  dividend  equivalent  rights. As  of  December  31,  2022  and  2021,  there  was  $37,000  and  $72,000  accrued  for
dividend equivalent rights which were included in other accrued expenses.

F-15

 
 
 
 
 
 
 
    
 
    
 
    
 
  
 
 
   
 
 
 
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE F – STOCKHOLDERS’ EQUITY (CONTINUED)

[2]

Stock Options

At December 31, 2022, there were no stock options outstanding. At December 31, 2021, one stock option to purchase 500,000 shares of common stock was outstanding,
representing an option grant outside of the 2013 Plan (issued prior to the establishment of the 2013 Plan). The stock option had a weighted average exercise price of
$1.19 and a weighted average remaining life of 0.84 years. There were no grants of stock options during the years ended December 31, 2022 and 2021.

The following table summarizes stock option activity for the years ended December 31:

Options outstanding at beginning of year
Granted
Expired
Exercised
Options outstanding at end of year
Options exercisable at end of year

2022

2021

Weighted
Average
Exercise
Price

Options
Outstanding

Weighted
Average
Exercise
Price

Options
Outstanding

$

$

500,000   
—   
—   
500,000   
—   
—   

1.19   
—   
—   
1.19   
—   
—   

500,000   
—   
—   
—   
500,000   
500,000   

$

$
$

1.19 
— 
— 
— 
1.19 
1.19 

During the year ended December 31, 2022 and 2021, the Company did not recognize any stock-based compensation related to the vesting of prior issued stock options to
employees. The Company at December 31, 2022 and 2021 had no remaining unrecognized expenses related to unvested stock options to employees and directors. The
aggregate intrinsic value of all stock options exercisable at December 31, 2022 and 2021 was $-0- and $815,000, respectively.

On October 27, 2022, the Company’s Chairman and Chief Executive Officer exercised a stock option to purchase 500,000 shares of the Company’s common stock at an
exercise  price  of  $1.19  per  share  on  a  net  exercise  (or  cashless)  basis.  In  connection  with  the  net  exercise  of  the  stock  option,  the  Company’s  Chairman  and  Chief
Executive Officer delivered 334,459 shares of common stock (including 94,539 shares for withholding taxes) to the Company and received 165,541 net shares.

NOTE G – MARKETABLE SECURITIES

Marketable securities as of December 31, 2022 and 2021 were composed of: 

Government Securities
Fixed income mutual funds
Certificates of Deposit
Corporate bonds and notes
Total marketable securities

Fixed income mutual funds
Corporate bonds and notes
Total marketable securities

Cost
Basis

20,781,000   
11,904,000   
3,019,000   
192,000   
35,896,000   

Cost
Basis

14,462,000   
813,000   
15,275,000   

$

$

$

$

$

$

$

December 31, 2022

Gross
Unrealized
Gains

Gross
Unrealized
Losses

67,000   
—   
—   
—   
67,000   

$

$

—   
(915,000)  
(43,000)  
(14,000)  
(972,000)  

December 31, 2021

Gross
Unrealized
Gains

Gross
Unrealized
Losses

—   
—   
—   

$

$

(137,000)  
(12,000)  
(149,000)  

$

$

$

$

Fair Value

20,848,000 
10,989,000 
2,976,000 
178,000 
34,991,000 

Fair Value

14,325,000 
801,000 
15,126,000 

F-16

 
 
 
 
 
 
 
 
    
 
    
 
    
 
  
 
 
   
 
 
 
 
   
   
 
   
 
 
 
 
   
   
 
   
 
 
 
   
   
   
 
 
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
  
 
 
 
 
    
 
    
 
    
 
  
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    
 
    
 
    
 
  
 
 
 
 
 
 
   
   
   
 
 
 
 
 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC. 

NOTE H – EQUITY INVESTMENT

During  the  period  December  2018  through  December  2022,  the  Company  made  an  aggregate  investment  of  $7,000,000  in  ILiAD,  a  privately  held  clinical  stage
biotechnology  company  dedicated  to  the  prevention  and  treatment  of  human  disease  caused  by  Bordetella  pertussis.  ILiAD  is  focused  on  validating  its  proprietary
intranasal vaccine, BPZE1, for the prevention of Pertussis (whooping cough). At December 31, 2022, the Company owned approximately 6.8% of the outstanding units
of  ILiAD  on  a  non-fully  diluted  basis  and  6.3%  of  the  outstanding  units  on  a  fully  diluted  basis  (after  giving  effect  to  the  exercise  of  all  outstanding  options  and
warrants). In connection with its investment, the Company’s Chairman and Chief Executive Officer obtained a seat on ILiAD’s Board of Managers and receives the same
compensation for service on the Board of Managers as other non-management Board members.

On August 24, 2022, ILiAD completed a private financing of $42,836,000 of its Class D units, of which a multi-national pharmaceutical company invested $30,000,000
(the “Financing”). As part of the Financing, the Company invested $1,000,000. This private financing represented an observable price transaction in accordance with
ASC 323 and resulted in dilution in the Company’s ownership in the ILiAD. In accordance with ASC 323-10-40-1, the Company accounted for the dilution as if it had
sold a portion of its investment and therefore recorded an unrealized gain of $3,883,000 and a corresponding increase in the carrying value of its investment in ILiAD.
The Company determined the new carrying value of its equity investment using an observable transaction price since the Company determined the securities owned by
the Company were not materially different than the securities sold by ILiAD in the Financing. The unrealized gain is reflected in the Company’s consolidated statements
of operations and comprehensive income (loss) for the year ended December 31, 2022.

In addition, as part of the Financing, the Company converted its convertible note in the principal amount of $1,000,000 plus accrued interest of $86,000, in accordance
with its terms, into equity of ILiAD and has accounted for this investment under the equity method of accounting. The Company recognized a gain on conversion of
$271,000 which was recognized in its consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.

For the years ended December 31, 2022 and 2021, the Company recorded an allocated net loss from its equity method investment in ILiAD of $1,639,000 and $999,000,
respectively.

The difference between the Company’s share of equity in ILiAD’s net assets and the purchase price of the investment is due to an excess amount paid over the book value
of the investment of $4,130,000, which is accounted for as equity method goodwill.

The Company performed an assessment to determine significance of its equity investee using the investment, asset and income tests. The Company concluded the income
test threshold was met for the year ended December 31, 2022. The following table provides certain summarized financial information for the Company’s equity method
investee for the periods presented and has been compiled from the equity investee’s financial statement, reported on one quarter lag.

Loss from continuing operations
Comprehensive loss

Twelve Months Ended September 30,

2022

2021

$
$

15,246,000   
17,913,000   

$
$

11,133,000 
10,384,000 

F-17

 
 
 
 
    
 
  
 
 
 
 
 
   
 
 
 
 
 
 
    
 
  
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE I – COMMITMENTS AND CONTINGENCIES

[1]

Legal fees:

Russ, August & Kabat provides legal services to the Company with respect to its pending patent litigation filed in May 2017 against Facebook, Inc. in the U.S. District
Court for the Southern District of New York relating to several patents within the Company’s Mirror Worlds Patent Portfolio (see Note K[2] hereof). The terms of the
Company’s agreement with Russ, August & Kabat provide for cash payments on a monthly basis subject to a cap plus a contingency fee ranging between 15% and 24%
of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is achieved. The Company is
responsible for all expenses incurred with respect to this litigation.

Russ, August & Kabat also provides legal services to the Company with respect to its pending patent litigations filed in April 2014 and December 2014 against Google
Inc.  and YouTube,  LLC  in  the  U.S.  District  Court  for  the  Southern  District  of  New York  relating  to  certain  patents  within  the  Cox  Patent  Portfolio  acquired  by  the
Company from Dr. Cox (see Note K[1] hereof). The terms of the Company’s agreement with Russ, August & Kabat provide for legal fees on a full contingency basis
ranging from 15% to 30% of the net recovery (after deduction of expenses) depending on the stage of the proceeding in which the result (settlement or judgment) is
achieved. The Company is responsible for all expenses incurred with respect to this litigation.

[2]

Patent Acquisitions:

On March 25, 2022, the Company completed the acquisition of a new patent portfolio (HFT Patent Portfolio) currently consisting of nine U.S. patents and two pending
U.S.  patents  covering  certain  advanced  technologies  relating  to  high  frequency  trading,  which  inventions  specifically  address  technological  problems  associated  with
speed and latency and provide critical latency gains in trading systems where the difference between success and failure may be measured in nanoseconds. The Company
paid the seller $500,000 at the closing and has an obligation to pay the seller an additional $500,000 in cash and $375,000 of the Company’s common stock (up to a
maximum of 375,000 shares) upon achieving certain milestones with respect to the HFT Patent Portfolio. The Company also has an additional obligation to pay the seller
15% of the first $50 million of net proceeds (after deduction of expenses) generated by the patent portfolio and 17.5% of net proceeds greater than $50 million.

In  connection  with  the  Company’s  acquisition  of  its  Cox  Patent  Portfolio,  the  Company  is  obligated  to  pay  Dr.  Cox  12.5%  of  the  net  proceeds  (after  deduction  of
expenses) generated by the Company from licensing, sale or enforcement of the patent portfolio. As of the years ended December 31, 2022, and 2021, no expense was
incurred with respect to the Cox Patent Portfolio. As of December 31, 2022 and 2021, no amounts were accrued with respect to the Cox Patent Portfolio.

As part of the acquisition of the Mirror Worlds Patent Portfolio, the Company also entered into an agreement with Recognition Interface, LLC (“Recognition”) pursuant
to which Recognition received from the Company an interest in the net proceeds realized from the monetization of the Mirror Worlds Patent Portfolio, as follows: (i) 10%
of the first $125 million of net proceeds; (ii) 15% of the next $125 million of net proceeds; and (iii) 20% of any portion of the net proceeds in excess of $250 million.
Since  entering  into  the  agreement  with  Recognition  in  May  2013,  the  Company  has  paid  Recognition  an  aggregate  of  $3,127,000  with  respect  to  such  net  proceeds
interest related to the Mirror Worlds Patent Portfolio. No such payments were made by the Company to Recognition during the year ended December 31, 2022 and 2021.

In connection with the Company’s acquisition of its M2M/IoT Patent Portfolio, the Company is obligated to pay M2M 14% of the first $100 million of net proceeds
(after  deduction  of  expenses)  and  5%  of  net  proceeds  greater  than  $100  million  from  Monetization Activities  (as  defined  in  the  acquisition  agreement)  related  to  the
M2MIoT Patent Portfolio. In addition, M2M will be entitled to receive from the Company $250,000 of additional consideration upon the occurrence of certain future
events related to the patent portfolio.

F-18

 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE I – COMMITMENTS AND CONTINGENCIES (CONTINUED)

[3]

Savings and investment plan:

The Company has a Savings and Investment Plan which allows participants to make contributions by salary reduction pursuant to Section 401(k) of the Internal Revenue
Code of 1986. The Company also may make discretionary annual matching contributions and profit sharing in amounts determined by the Board of Directors, subject to
statutory  limits. The  401(k)  Plan  expense  for  the  years  ended  December  31,  2022  and  2021  was  $78,000  and  $102,000,  respectively,  all  of  which  was  accrued  as  of
December 31, 2022 and 2021 and is recorded within accrued expenses on the Company’s consolidated balance sheets.

[4]

Leases:

The Company has one operating lease for its principal office space in New Canaan, Connecticut that will expire on April 30, 2025.

There are no material residual guarantees associated with the Company’s lease and there are no significant restrictions or covenants included in the Company’s lease.

The calculated incremental borrowing rate was approximately 4.2%, which was calculated based on remaining lease term of 3 years as of May 1, 2022. The remaining
lease term as of December 31, 2022 was approximately 2.3 years.

There was no sublease rental income for the year ended December 31, 2022, and the Company is not the lessor in any lease arrangement, and there were no related-party
lease agreements.

Right-of-use lease assets and related lease obligations for the Company’s operating leases were recorded in the consolidated balance sheet as follows:

Operating lease right-of-use assets

Operating lease obligations – current
Operating lease obligations – non-current
Total lease obligations

As of
December 31, 2022   
161,000   
$

As of
December 31, 2021  
— 
$

79,000   
94,000   
173,000   

$

$

— 
— 
— 

The table below presents certain information related to the Company’s lease costs for the year ended December 31, 2022 and 2021:

Operating lease cost
Short-term lease cost
Total lease cost

For the Year Ended
December 31,

2022

48,000   
82,000   
130,000   

$

$

2021

— 
128,000 
128,000 

$

$

Future lease payments included in the measurement of lease liabilities on the consolidated balance sheet as of December 31, 2022, were as follows:

  2023
  2024
  2025
  Total future minimum lease payments
  Less imputed interest
  Total operating lease liability

Operating Leases

83,000 
73,000 
24,000 
180,000 
(7,000)
173,000 

$

F-19

 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
   
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
 
 
 
 
 
    
 
  
 
 
 
 
 
   
 
 
 
 
 
 
 
 
   
 
  
 
   
 
   
 
   
 
   
 
   
 
   
 
   
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE J - EMPLOYMENT ARRANGEMENTS AND OTHER AGREEMENTS

[1] On March 22, 2022, the Company entered into a new employment agreement (“Agreement”) with its Chairman and Chief Executive Officer, pursuant to which he
continues to serve as the Company’s Chairman and Chief Executive Officer for a four-year term (“Term”), at an annual base salary of $535,000 which shall be increased
by  3%  per  annum  during  the  Term.  The  Agreement  established  an  annual  target  bonus  of  $175,000  for  the  Chairman  and  Chief  Executive  Officer  based  upon
performance. For the year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer received an annual discretionary bonus of $175,000.

In addition, pursuant to the Agreement, the Company granted the Chairman and Chief Executive Officer, under its 2013 Plan, 600,000 restricted stock units (the “RSUs”,
each RSU awarded by the Company to its officers, directors and consultants represents a contingent right to receive one share of the Company’s common stock) which
terms provided for vesting in four tranches, as follows: (1) 175,000 RSUs which shall vest 100,000 RSUs on March 22, 2023 and 75,000 RSUs on March 22, 2024,
subject to the Chairman and Chief Executive Officer’s continued employment by the Company through each such vesting date (the “Employment Condition”) (“Tranche
1”); (2) 150,000 RSUs shall vest if at any time during the Term that the Company’s common stock achieves a closing price for twenty (20) consecutive trading days
(“Closing Price”) of a minimum of $3.50 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per
share Closing Price is achieved (“Tranche 2”); (3) 150,000 RSUs shall vest if at any time during the Term that the common stock achieves a Closing Price of a minimum
of $4.00 per share (subject to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved
(“Tranche 3”); and (4) 125,000 RSUs shall vest if at any time during the Term, that the common stock achieves a Closing Price of a minimum of $4.50 per share (subject
to adjustment for stock splits) and the Employment Condition is satisfied through the date such minimum per share Closing Price is achieved (“Tranche 4”). In the event
of a Change of Control (as defined), Termination Other Than for Cause (as defined) or a termination by the Chairman and Chief Executive Officer for Good Reason (as
defined) in each case prior to the last day of the Term, the vesting of all RSUs (Tranches 1, 2, 3 and 4) shall accelerate (and not be subject to any conditions) and all
RSUs shall become immediately fully vested. All RSUs granted by the Company to its officers, directors or consultants have dividend equivalent rights.

Under the terms of the Agreement, so long as the Chairman and Chief Executive Officer continues to serve as an executive officer of the Company, whether pursuant to
the Agreement or otherwise, the Chairman and Chief Executive Officer shall also receive incentive compensation in an amount equal to 5% of the Company’s gross
royalties or other payments from Licensing Activities (as defined) (without deduction of legal fees or any other expenses) with respect to the Remote Power Patent and a
10% net interest (gross royalties and other payments after deduction of all legal fees and litigation expenses related to licensing, enforcement and sale activities, but in no
event shall he receive less than 6.25% of the gross recovery) of the Company’s royalties and other payments relating to Licensing Activities with respect to patents other
than the Remote Power Patent (including all of the Company’s patent portfolios and its investment in ILiAD) (collectively, the “Incentive Compensation”). During the
year ended December 31, 2022 and 2021, the Chairman and Chief Executive Officer earned Incentive Compensation of $-0- and $1,801,000, respectively.

The Incentive Compensation shall continue to be paid to the Chairman and Chief Executive Officer for the life of each of the Company’s patents with respect to licenses
entered  into  with  third  parties  during  the  term  of  his  employment  or  at  anytime  thereafter,  whether  he  is  employed  by  the  Company  or  not;  provided,  that,  the
employment  of  the  Chairman  and  Chief  Executive  Officer  has  not  been  terminated  by  the  Company  “For  Cause”  (as  defined)  or  terminated  by  him  without  “Good
Reason” (as defined). In the event of a merger or sale of substantially all of the Company’s assets, the Company has the option to extinguish the right of the Chairman
and Chief Executive Officer to receive future Incentive Compensation by payment to him of a lump sum payment, in an amount equal to the fair market value of such
future  interest  as  determined  by  an  independent  third  party  expert  if  the  parties  do  not  reach  agreement  as  to  such  value.  In  the  event  that  the  Chairman  and  Chief
Executive Officer’s employment is terminated by the Company “Other Than For Cause” (as defined) or by him for “Good Reason” (as defined), the Chairman and Chief
Executive Officer shall also be entitled to (i) a lump sum severance payment of 12 months base salary, (ii) a pro-rated portion of the $175,000 target bonus provided
bonus criteria have been satisfied on a pro-rated basis through the calendar quarter in which the termination occurs and (iii) accelerated vesting of all unvested options,
RSUs or other awards.

F-20

 
  
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE J - EMPLOYMENT ARRANGEMENTS AND OTHER AGREEMENTS (CONTINUED)

In connection with the Agreement, the Chairman and Chief Executive Officer has also agreed not to compete with the Company as follows: (i) during the Term of the
Agreement and for a period of 12 months thereafter if his employment is terminated “Other Than For Cause” (as defined) provided he is paid his 12 months base salary
severance amount and (ii) for a period of two years from the termination date, if terminated “For Cause” by the Company or “Without Good Reason” by the Chairman
and Chief Executive Officer.

[2]  The  Company’s  Executive Vice  President  serves  on  an  at-will  basis  at  an  annual  base  salary  of  $200,000. The  Executive Vice  President  received  a  discretionary
annual bonus of $25,000 and $40,000 for the year ended December 31, 2022 and 2021, respectively. On January 18, 2022, the Company’s Executive Vice President was
granted 15,000 RSUs under the 2013 Plan, 50% of such RSUs vested on the one year anniversary of the date of grant (January 18, 2023) and 50% of such RSUs vest on
the two year anniversary of the grant (January 18, 2024), subject to continued employment. On January 24, 2023, the Company’s Executive Vice President was granted
15,000 RSUs under the 2022 Plan, 50% of such RSUs vest on the one year anniversary of the date of grant (January 24, 2024) and 50% of such RSUs vest on the two
year anniversary of the date of grant (January 24, 2025), subject to continued employment.

[3] The Company’s former Chief Financial Officer served on an at-will basis at an annual base salary of $175,000 until his retirement in December 2022. In connection
with his retirement, the Chief Financial Officer was granted severance of 6 months base salary and certain other benefits.

[4] In December 2022, the Company’s Board of Directors elected a new Chief Financial Officer who serves on a consulting basis at an annual base salary of $175,000.

NOTE K – LEGAL PROCEEDINGS

[1] On April 4, 2014 and December 3, 2014, the Company initiated litigation against Google Inc. (“Google”) and YouTube, LLC (“YouTube”) in the U.S. District Court
for the Southern District of New York for infringement of several of its patents within its Cox Patent Portfolio acquired from Dr. Cox which relate to the identification of
media content on the Internet. The lawsuit alleges that Google and YouTube have infringed and continue to infringe certain of the Company’s patents by making, using,
selling  and  offering  to  sell  unlicensed  systems  and  related  products  and  services,  which  include  YouTube’s  Content  ID  system.  The  litigations  against  Google  and
YouTube were subject to court ordered stays which were in effect from July 2, 2015 until January 2, 2019 as a result of proceedings at the Patent Trial and Appeal Board
(PTAB)  and  the  appeals  of  PTAB  Final Written  Decisions  to  the  U.S.  Court  of Appeals  for  the  Federal  Circuit.  Pursuant  to  a  Joint  Stipulation  and  Order  Regarding
Lifting of Stays, entered on January 2, 2019, the parties agreed, among other things, that the stays with respect to the litigations were lifted. In January 2019, the two
litigations against Google and YouTube were consolidated. Discovery is complete and the parties have each submitted summary judgment motions. A trial date has not
yet been set.

[2] On May 9, 2017, Mirror Worlds Technologies, LLC, the Company’s wholly-owned subsidiary, initiated litigation against Facebook, Inc. (“now Meta Platforms, Inc.
(“Meta”)) in the U.S. District Court for the Southern District of New York, for infringement of U.S. Patent No. 6,006,227, U.S. Patent No. 7,865,538 and U.S. Patent No.
8,255,439  (among  the  patents  within  the  Company’s  Mirror  Worlds  Patent  Portfolio).  The  lawsuit  alleged  that  the  asserted  patents  are  infringed  by  Meta’s  core
technologies that enable Meta’s Newsfeed and Timeline features. On May 7, 2018, Meta filed a motion for summary judgment on non-infringement. On August 11, 2018,
the Court issued an order granting Meta’s motion for summary judgment of non-infringement and dismissed the case. On August 17, 2018, the Company filed a Notice of
Appeal to appeal the summary judgment decision to the U.S. Court of Appeals for the Federal Circuit. On January 23, 2020, the U.S. Court of Appeals for the Federal
Circuit ruled in the Company’s favor and reversed the summary judgment finding on non-infringement of the District Court and remanded the litigation to the Southern
District of New York for further proceedings.

F-21

 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE K – LEGAL PROCEEDINGS (CONTINUED)

On March 7, 2022, the District Court entered a ruling granting in part and denying in part a motion for summary judgment by Meta. In its ruling the Court (i) denied
Meta’s motion that the asserted patents were invalid by concluding that all asserted claims were patent eligible under §101 of the Patent Act and (ii) granted summary
judgment of non-infringement in favor of Facebook and dismissed the case. The Company strongly disagrees with the decision on non-infringement and on April 4, 2022,
the Company filed an appeal to the U.S. Court of Appeals for the Federal Circuit, which is pending.

[3] On December 15, 2020, the Company filed a lawsuit against Netgear, Inc. (“Netgear”) in the Supreme Court of the State of New York, County of New York, for
breach of a Settlement and License Agreement, dated May 22, 2009, with the Company for failure to make royalty payments, and provide corresponding royalty reports,
to the Company based on sales of Netgear’s PoE products. On October 22, 2021, Netgear filed a Demand for Arbitration at the American Arbitration Association (AAA)
seeking to arbitrate certain issues raised in the litigation. The Company objected to jurisdiction at the AAA. On April 22, 2022, Netgear filed a counterclaim in the N.Y.
court  action  alleging  that  the  Company  breached  the  License Agreement  by  not  offering  Netgear  lower  royalties.  On  September  22,  2022,  the  arbitration  brought  by
Netgear was dismissed by the AAA on jurisdiction grounds. The case remains pending in the Supreme Court of the State of New York, County of New York.

[4]  In  October  and  November  2022,  the  Company  initiated  separate  litigation  against  ten  defendants  for  infringement  of  its  Remote  Power  Patent  seeking  monetary
damages  based  upon  reasonable  royalties,  as  follows:  (i)  On  October  6,  2022,  the  Company  initiated  such  litigation  against  Arista  Networks,  Inc.,  Fortinet,  Inc.,
Honeywell International Inc. and Ubiquiti Inc. in the United States District Court, District of Delaware; (ii) On October 27, 2022, and November 3, 2022, the Company
initiated  such  litigation  against TP-Link  USA  Corporation  and  Hikvision  USA,  Inc.  in  the  United  States  District  Court  for  the  Central  District  of  California;  (iii)  On
November  4,  2022,  the  Company  initiated  such  litigation  against  Panasonic  Holdings  Corporation  and  Panasonic  Corporation  of  North America  in  the  United  States
District Court for the Eastern District of Texas (Marshall Division); and (iv) On November 8, 2022 and November 16, 2022, the Company initiated such litigation against
Antaira Technologies, LLC and Dahua Technology USA in the United States District Court for the Central District of California.

NOTE L - CONCENTRATIONS

The Company had no revenue for the year ended December 31, 2022. Revenue from the Company’s Remote Power Patent constituted 100% of the Company’s revenue
for the year ended December 31, 2021, of which two licensees constituted an aggregate of 99% of the Company’s revenue for such year.

NOTE M – RELATED PARTY TRANSACTION

On  June  1,  2022,  the  Company  repurchased  from  a  director  of  the  Company  41,500  shares  of  its  common  stock  at  a  purchase  price  of  $2.42  per  share  or  aggregate
consideration of $100,430.

NOTE N – STOCK REPURCHASE PROGRAM

On  June  11,  2021,  the  Company’s  Board  of  Directors  authorized  an  extension  and  increase  of  the  Share  Repurchase  Program  to  repurchase  up  to  $5,000,000  of  the
Company’s  common  stock  over  the  subsequent  24-month  period. The  common  stock  may  be  repurchased  from  time  to  time  in  open  market  transactions  or  privately
negotiated transactions in the Company’s discretion. The timing and amount of the shares repurchased are determined by management based on its evaluation of market
conditions and other factors. The repurchase program may be increased, suspended or discontinued at any time.

During the year ended December 31, 2022, the Company repurchased an aggregate of 228,530 shares of its common stock pursuant to the Share Repurchase Program at a
cost of approximately $531,000 (exclusive of commissions) or an average price per share of $2.33.

Since  inception  of  the  Share  Repurchase  Program  (August  2011)  through  December  31,  2022,  the  Company  has  repurchased  an  aggregate  of  9,212,664  shares  of  its
common stock at a cost of approximately $17,758,000 (exclusive of commissions) or an average per share price of $1.93.

F-22

 
 
 
 
 
 
 
 
NETWORK-1 TECHNOLOGIES, INC.

NOTE O – DIVIDEND POLICY

The Company’s dividend policy consists of a semi-annual cash dividend of $0.05 per common share ($0.10 per common share annually) which have been paid in March
and September of each year. On February 23, 2022, the Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 24,
2022 to all common shareholders of record as of March 9, 2022. On September 9, 2022, the Board of Directors declared a semi-annual dividend of $0.05 per share with a
payment date of September 30, 2022 to all common shareholders of record as of September 20, 2022. The Company’s dividend policy undergoes a periodic review by the
Board of Directors and is subject to change at any time depending upon the Company’s earnings, financial requirements and other factors.

NOTE P – SUBSEQUENT EVENTS

[1] On March 3, 2023, the Company’s Board of Directors declared a semi-annual cash dividend of $0.05 per share with a payment date of March 31, 2023 to all common
shareholders of record as of March 15, 2023.

[2] On March 3, 2023, the Company’s Board of Directors approved the grant of 15,000 RSUs to each of the Company’s three non-management directors. The RSUs vest
over a one year period in equal quarterly installments of 3,750 shares of common stock on each of March 15, 2023, June 15, 2023, September 15, 2023 and December 15,
2023.

[3] During the period January 24, 2023 through March 10, 2023, the Company entered into settlement agreements with Arista Networks, Inc., Antiara Technologies LLC,
Panasonic Holdings Corporation and TP-Link USA Corporation with respect to patent infringement litigation involving its Remote Power Patent, resulting in aggregate
settlement payments to the Company of $537,300 and a conditional payment of $150,000 (see Note K[4] hereof).

F-23

 
 
 
 
 
 
 
 
 
 
 
 
 
ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES

(a)(1)       Financial Statements:

PART IV

The following are included under Item 8 “Financial Statements and Supplementary Data”:

Report of Independent Registered Public Accounting Firm
Consolidated balance sheets as of December 31, 2022 and 2021
Consolidated statements of operations and comprehensive (loss) income for the years ended December 31, 2022 and 2021
Consolidated statements of changes in stockholders' equity for the years ended December 31, 2022 and 2021
Consolidated statements of cash flows for the years ended December 31, 2022 and 2021
Notes to consolidated financial statements

(a)(2)       Financial Statements Schedules:

Financial statement schedules are omitted because the information is not applicable.

-46-

 
 
 
 
 
 
 
(a)(3) Exhibits:

3(i)(a)

Certificate of Incorporation, as amended. Previously filed as Exhibit 3.1 to the Company’s Registration Statement on Form SB-2 (Registration No. 333-
59617), declared effective by the SEC on November 12, 1998 (the “1998 Registration Statement”), and incorporated herein by reference.

3(i)(b)

Certificate of Amendment to the Certificate of Incorporation dated November 27, 2001. Previously filed as Exhibit 3.1.1 to the Company’s Registration
Statement  on  Form  S-3  (Registration  No.  333-81344)  declared  effective  by  the  SEC  on  February  12,  2002,  and  incorporated  herein  by  reference  (the
“February 2002 Form S-3”)

3(i)(c)

Certificate of Amendment to the Certificate of Incorporation dated October 9, 2013. Previously filed as Exhibit 3.1 to the Company’s Current Report on
Form 8-K filed on October 10, 2013, and incorporated herein by reference.

3(ii)

4.1

10.2+

10.3+

10.4+

+

10.5

Second Amended and Restated By-laws. Previously filed as Exhibit 3.1 to the Company’s Quarterly Report on Form 10-Q for the quarterly period ended
September 30, 2016 filed on November 14, 2016 and incorporated herein by reference.

Description  of  Common  Stock.  Previously  filed  under  the  header  “Common  Stock”  under  the  section  captioned  “Description  of  Securities”  in  the
Company’s Registration Statement on Form S-1A (File No. 333-190719) filed on September 30, 2014 and incorporated herein by reference.

Employment Agreement, dated July 14, 2016, between the Company and Corey M. Horowitz, Chairman and Chief Executive Officer. Previously filed as
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on July 19, 2016 and incorporated herein by reference.

Employment Agreement, dated March 22, 2022, between the Company and Corey M. Horowitz, Chairman and Chief Executive Officer. Previously filed as
Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on March 28, 2022 and incorporated herein by reference.

2013 Stock Incentive Plan. Previously filed as Appendix B to the Company’s Schedule 14A (Proxy Statement) filed on August 20, 2013 and incorporated
herein by reference.

2022 Stock Incentive Plan Previously filed as Exhibit A to the Company's Schedule 14A (Proxy Statement) filed on July 27, 2022 and incorporated herein
by reference.

-47-

 
 
 
 
 
 
 
10.6

Form  of  Indemnification Agreement  for  directors  and  officers.  Previously  filed  as  Exhibit  10.1  to  the  Company’s  Current  Report  on  Form  8-K  filed  on
December 13, 2019 and incorporated herein by reference.

14

16

Code of Ethics. Previously filed as Exhibit 14 to the Company's Annual Report on Form 10-KSB for the year ended December 31, 2004 filed on April 14,
2004 and incorporated herein by reference.

Letter, dated October 12, 2002, from Friedman LLP. Previously filed as Exhibit 16 to the Company’s Current Report on Form 8-K filed on October 12,
2022 and incorporated herein by reference.

21.1*

List of Subsidiaries of Registrant.

23.1*

Consent of Marcum LLP, independent registered public accounting firm.

23.2

Consent of Friedman LLP, the Company’s former independent registered public accounting firm.

31.1*

Section 302 Certification of Chief Executive Officer.

31.2*

Section 302 Certification of Chief Financial Officer.

32.1*

Section 906 Certification of Chief Executive Officer.

32.2*

Section 906 Certification of Chief Financial Officer.

101* Interactive data files: *

101.INS       XBRL Instance Document.

101.SCH       XBRL Scheme Document.

101.CAL       XBRL Calculation Linkbase Document.

101.DEF       XBRL Definition Linkbase Document.

101.LAB       XBRL Label Linkbase Document.

101.PRE       XBRL Presentation Linkbase Document.
_________________________________________________________________ 

*  Filed herewith
+  Management contract or compensatory plan or arrangement

-48-

 
 
 
 
 
 
 
 
 
 
 
 
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the

undersigned, thereunto duly authorized.

SIGNATURES

NETWORK-1 TECHNOLOGIES, INC.

By  /s/ Corey M. Horowitz                               

Corey M. Horowitz
Chairman and Chief Executive Officer
March 30, 2023

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the

capacities and on the dates indicated:

NAME

TITLE

  DATE

/s/ Corey M. Horowitz

Corey M. Horowitz

/s/ Robert Mahan

Robert Mahan

/s/ Jonathan Greene

Jonathan Greene

/s/ Emanuel Pearlman

Emanuel Pearlman

/s/ Niv Harizman

Niv Harizman

/s/ Allison Hoffman

Allison Hoffman

Chairman and Chief Executive Officer, Chairman of the Board of
Directors (principal executive officer)

March 30, 2023

Chief Financial Officer (principal financial officer and principal
accounting officer)

March 30, 2023

Executive Vice President, Secretary and a Director

March 30, 2023

Director

Director

Director

 March 30, 2023

 March 30, 2023

 March 30, 2023

-49-

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 21.1

List of Subsidiaries of Network-1 Technologies, Inc.

Name

Mirror Worlds Technologies, LLC

HFT Solutions, LLC

Jurisdiction

Delaware

Delaware

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in the Registration Statements of Network-1 Technologies, Inc. on Form S-8 Nos. 333-192811, 333-186612 and 333-269142 of
our report dated March 30, 2023, with respect to our audit of the consolidated financial statements of Network-1 Technologies, Inc. as of and for the year ended December 31,
2022, which report is included in this Annual Report on Form 10-K of Network-1 Technologies, Inc. for the year ended December 31, 2022.

EXHIBIT 23.1

/s/ Marcum LLP

Marcum LLP
New York, New York
March 30, 2023

 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 23.2

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

We consent to the incorporation by reference in the Registration Statements of Network-1 Technologies, Inc. and Subsidiary on Form S-8 Nos. 333-192811, 333-186612, and
333-269142  of  our  report  dated  March  30,  2022,  with  respect  to  our  audit  of  the  consolidated  financial  statements  of  Network-1  Technologies,  Inc.  and  Subsidiary  as  of
December 31, 2021, which report is included in the Annual Report on Form 10-K of Network-1 Technologies, Inc. and Subsidiary for the year ended December 31, 2022.

We resigned as auditors on October 11, 2022, and, accordingly, we have not performed any audit or review procedures with respect to any financial statements for the periods
after the date of our resignation.

/s/ Friedman LLP

New York, New York
March 30, 2023

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350)

I, Corey M. Horowitz, Chairman and Chief Executive Officer of Network-1 Technologies, Inc. (the "Registrant"), certify that:

1. I have reviewed this report on Form 10-K for the year ended December 31, 2022 of the Registrant;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-
15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material

information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this
report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide

reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the

disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the

Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over
financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and
the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely

affect the Registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial

reporting.

Date:   March 30, 2023

/s/ Corey M. Horowitz
Corey M. Horowitz
Chairman and Chief Executive Officer

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. §1350)

I, Robert M. Mahan, Chief Financial Officer of Network-1 Technologies, Inc. (the "Registrant"), certify that:

1. I have reviewed this report on Form 10-K for the year ended December 31, 2022 of the Registrant;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results
of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4. The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-
15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material

information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this
report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide

reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted
accounting principles;

(c) Evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the

disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the

Registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over
financial reporting; and

5. The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and
the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely

affect the Registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial

reporting.

Date:  March 30, 2023

/s/ Robert M. Mahan
Robert M. Mahan
Chief Financial Officer

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. §1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Corey M. Horowitz, Chairman and Chief Executive
Officer of Network-1 Technologies, Inc., a Delaware corporation (the "Company"), does hereby certify that:

The Annual Report on Form 10-K for the year ended December 31, 2022 of the Company (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.

EXHIBIT 32.1

/s/ Corey M. Horowitz                                     
Chief Executive Officer and Chairman
March 30, 2023

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXHIBIT 32.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. §1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned, Robert M. Mahan, Chief Financial Officer of Network-1
Technologies, Inc., a Delaware corporation (the "Company"), does hereby certify that:

The Annual Report on Form 10-K for the year ended December 31, 2022 of the Company (the "Report") fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934, and the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the
Company.

/s/ Robert M. Mahan                                    
Chief Financial Officer
March 30, 2023